How many investments has F-Prime Capital made?

F-Prime Capital has 445 tracked investments, 76 of which have exited, including 23 dated in the last 24 months.

What stage does F-Prime Capital invest at?

F-Prime Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What is F-Prime Capital's typical check size?

F-Prime Capital typically writes checks of $3M – $10M.

Where is F-Prime Capital located?

F-Prime Capital is headquartered in Cambridge, US.

Does F-Prime Capital lead rounds?

Yes, F-Prime Capital leads investment rounds.

Who does F-Prime Capital co-invest with?

F-Prime Capital most often shares deals with ARCH Venture Partners, GV (Google Ventures), Eight Roads Ventures, among 677 tracked co-investors.

F-Prime Capital

Venture capitaloperating company · company profile

Cambridge · Pre-Seed–Late Stage · 110 people tracked

Also known as F-Prime Capital Partners · IMPRESA MANAGEMENT LLC

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into F-Prime Capital

4,004 people in our graph share verified history with the F-Prime Capital team — schools, employers, funds. One of them is your warm intro.

Laura Buhlerunlockedknows Jessica Alston · together at McKinsey & Company (overlapped)

knows the team · via Harvard University

×2knows the team · via Y Combinator

×2knows the team · via Broad Institute of MIT and Harvard

knows the team · via Summit Partners

knows the team · via Equip Health

✨ Fox Verdict

Investment thesis

F-Prime backs founders across healthcare and technology with a preference for early-stage investing, though it will support exceptional teams at any stage. In healthcare, it focuses on therapeutics, medtech, and healthtech plus services in a stage-agnostic manner. In technology, it targets enterprise software, fintech, frontier tech, and crypto. The firm draws on a legacy spanning more than 50 years and a team of scientists, engineers, physicians, operators, and investors who bring real-world expertise to help companies accelerate toward scalable growth.

Invests inBiotech Crypto & Web3 Deep Tech Digital Health Enterprise Software Fintech Healthtech Medical Devices SaaSSector AgnosticAsia-Pacific Boston Cambridge China Europe Global Mexico North America United States

Source: firm website, verified Aug 26, 2026.

Stage

Pre-Seed–Late Stage

Check

$3M – $10M

Cambridge, Massachusetts, US

Leads rounds

Leads

Instruments

Equity

Founded

2002

Last 12 months

11 investments

AUM

$13B

Tracked investments

445

Unicorns

IPOs

Acquisitions

Team · 110 people

from the firm's website & curated & public directories

David Jegen· Managing Partner, Tech Fund· Cambridgein 𝕏

David Jegen is Managing Partner of F-Prime's Tech Fund, investing at the intersection of fintech and enterprise software, with led investments including Flywire, Toast, Snapdocs, and Kensho. He previously co-founded Sensoria, held roles at Cisco, J.P. Morgan, and BCG, co-founded the nonprofit Fintech Sandbox in 2015, and holds a Harvard Law degree plus economics and accounting degrees from Indiana University.

d•••@fprimecapital.comreveal

Alex Pasteur· Partner, PhD· Londonin

Alex Pasteur joined F-Prime in 2012 as a London-based Partner focused on therapeutics and life sciences investments. He was a founding investor in ARTBIO, Tenpoint Therapeutics and Orchard Therapeutics, and has worked in healthcare investing since 2001, previously at MVM Life Science Partners. He holds an M.A. in Natural Sciences and a PhD in Chemistry, both from Cambridge University.

a•••@fprimecapital.comreveal

Brett Cook· Partner· Cambridgein

Brett Cook is a Partner at F-Prime focused on healthcare technology and services investments, having led or participated in deals including Iora Health, PatientPing, 1up Health, Equip, NOCD, and Proximie. He rejoined F-Prime in 2018 after leading finance at PatientPing and working at Aledade and McKinsey; he holds an MBA from Harvard and a BSE in Biomedical Engineering from Duke.

Carl Byers· Partner· Cambridgein 𝕏

Carl Byers is a Partner with deep operating experience in healthcare IT. He was on the founding team of athenahealth, serving as CFO from 1997 to 2010, where he built the firm's financial systems, led multiple financing rounds, and drove its 2007 IPO. He previously consulted at Booz, Allen & Hamilton and teaches finance at Harvard's Chan School of Public Health.

c•••@fprimecapital.comreveal

Chong Xu· Partner· Cambridgein

Chong Xu is a Partner at F-Prime focused on biopharmaceutical and medical technology, and collaborates with the Eight Roads Ventures Asia team on portfolio and investment opportunities in China. He joined F-Prime in 2015 after roles at McKinsey, hedge funds Massif Partners and Affirmed Healthcare, and neurobiology research at Temasek Life Sciences Laboratory; he holds a PhD in Cell Biology and an MBA from the University of Virginia and a biology degree from Zhejiang University.

Gaurav Tuli· Partner· Boston, Massachusettsin

Jessica Alston· Partner· Boston, Massachusettsin

j•••@fprimecapital.comreveal

Jon Lim· Partner· Boston, Massachusettsin

Jon Lim is a Partner at F-Prime Capital Partners, where he leads venture and growth equity investments focused on healthtech and services companies through Fidelity's healthcare-focused venture fund.

j•••@fprimecapital.comreveal

Ketan Patel· Partner· Cambridge, Massachusettsin

k•••@fprimecapital.comreveal

M. Jackson Wilkinson· Venture and Operating Partner· Boston, Massachusetts, United Statesin

M. Jackson Wilkinson is a Venture and Operating Partner at F-Prime Capital, where he focuses on health technology. His background spans product, design, and engineering leadership, with an emphasis on healthcare-related technology and user experience.

Nihal Sinha· Partner· Londonin

n•••@fprimecapital.comreveal

Rocio Wu· Partner· San Francisco Bay Areain

Rocio Wu is a Partner at F-Prime Capital, where she leads investments in Vertical AI, AI Infrastructure, and Fintech. Her early-stage investments include Fazeshift, Toku, Kanastra, Pie, Mercury, Together AI, Inworld, Overjet, and Chipper Cash. Prior to her investing career, she held operating roles in corporate development, go-to-market strategy, and growth at Google and Amazon across the United States, Japan, Spain, and China.

Sachin Patodia· Partner

Sanjay Aggarwal· Partner· Cambridge, Massachusettsin

Sanjay Aggarwal is a Venture Partner at F-Prime Capital who invests in early-stage physical AI and enterprise AI companies. He also works with portfolio companies operating in the India-US corridor.

Shyam Kamadolli· Managing Director - Fine Structure Ventures· Boston, Massachusettsin 𝕏

Shyam Kamadolli is Managing Director at Fine Structure Ventures, with over 25 years of experience as a deep-tech entrepreneur and early-stage investor. He previously led global VC investments at Applied Crypto Ventures, F-Prime Capital, Eight Roads Capital, and Fidelity Ventures, and earlier led business development at RSA Security and co-founded several venture-backed startups. He holds a BE in Computer Engineering from the University of Bombay, an MS in Electrical Engineering from Clarkson University, and MBAs from Columbia Business School and London Business School.

s•••@finestructure.vcreveal

Bala Varadhan· Principal· Cambridgein

Principal at F-Prime focused on early-stage crypto, blockchain, and Web3 investments. Previously worked at Avon Ventures and BCG on private equity due diligence and growth strategy, with earlier roles in private equity and law. Holds an MBA from Kellogg, a JD from Pritzker School of Law, and dual B.A.s from UT Austin.

Ben Gorman· Principal· San Franciscoin 𝕏

Principal at F-Prime focused on early-stage investments in enterprise software and AI. Previously a managing consultant at IBM working on data- and ML-driven go-to-market transformation, and a Carnegie Mellon graduate in Statistics and Economics.

Betsy Mulé· Principal· San Franciscoin 𝕏

Principal at F-Prime focused on early-stage investments in enterprise technology and robotics. Previously a strategy consultant at Mars & Co. advising Fortune 500 companies across the US, Latin America and Europe. Holds a degree in Chemical-Biological Engineering from MIT.

Brian Yordy· Principal· Cambridgein

Brian Yordy joined F-Prime in 2018 and focuses on biopharmaceutical and medical technology investments. He previously was an engagement manager at McKinsey and Company advising pharma and medtech companies, and holds a PhD in immunology from Yale and a B.S. in biochemistry from Notre Dame.

Connie Li· Principal· San Franciscoin

Connie Li is a Principal on F-Prime's life sciences team focused on biotechnology investments, and collaborates with the Eight Roads Ventures China team on F-Prime's China investments. She joined F-Prime in 2019, was involved in forming companies including K36 Tx, Skyline, Pediatrix, and AlphaGen, and previously worked as a consultant at IQVIA advising biopharma companies. She holds an MBA and MS from Harvard and a BSE in Bioengineering from the University of Pennsylvania.

Hannah Arnold· Principal· Cambridge, Massachusettsin 𝕏

Kevin Chu· Principal· San Francisco, Californiain

k•••@fprimecapital.comreveal

Nikhil Marathe· Principal· Boston, Massachusetts, United Statesin

Nikhil Marathe is Principal and Head of Growth Equity at F-Prime, where he focuses on funding healthcare software and services businesses. He previously worked at Silversmith, TA Associates, and Evercore.

Amrit Jalan· Principal· Bostonin

Amrit Jalan is a Principal at Fine Structure Ventures, where he works on identifying emerging technologies and helping teams turn scientific advances into scalable companies. He was previously a Director at Eni Next, the venture arm of Eni S.p.A., where he led investments from Seed to Series B in decarbonization, advanced materials, and energy transition, and earlier held technology, strategy, and commercialization roles at ExxonMobil. He holds an MBA from Harvard Business School, MS/PhD degrees in Chemical Engineering from MIT, and a BS in Chemical Engineering from IIT Bombay.

Evelyn Ng· Senior Director of Financein

Evelyn Ng oversees financial operations at Flourish Ventures, managing valuations, accounting, budgeting, financial systems, audits, reporting, and financial compliance. She has a background in valuations and finance and played an instrumental role in completing Flourish's operations setup.

Allison MacLeod· Venture Partner· Cambridgein

Allison MacLeod is CMO of Flywire (Nasdaq: FLYW), where she leads global marketing and revenue operations and helped guide the company to its 2021 IPO. She has over 15 years of marketing experience, including roles at Rapid7 and Forrester, and advises early-stage companies.

Amber Cai· Venture Partner· Cambridge

Venture Partner at F-Prime focused on early-stage biotechnology investments, and founding CEO of gene and cell therapy company Skyline Therapeutics. She was previously a founding member and Head of Operations of Novartis' R&D Center in China, holds a PhD from MIT in GPCR signaling, and an MBA from MIT Sloan.

Bobby Gaspar· Venture Partner, MD, PhD· Londonin

A physician-scientist with over 25 years in medicine and biotechnology, Bobby Gaspar is a Venture Partner at F-Prime based in London. He is a scientific founder and CEO of Orchard Therapeutics, a pioneer in hematopoietic stem cell gene therapy, chair of Eligo Biosciences, and an honorary professor of pediatrics and immunology at UCL Great Ormond Street Institute of Child Health.

Carlos Bustamante· Venture Partner, PhD· San Franciscoin

Carlos Bustamante joined F-Prime in January 2019 as a Venture Partner in the San Francisco office, focusing on applying data science and genomics to problems in medicine, agriculture, and biology. He is on leave from Stanford University, where he is a Professor of Biomedical Data Science, Genetics, and Biology, and has founded and directed multiple academic units and companies. He holds a PhD in Biology and MS in Statistics from Harvard University.

Catherine Stehman-Breen· Venture Partner· Cambridge

Venture Partner at F-Prime based in the Cambridge office, focused on new company creation, with over 30 years of medical and biopharmaceutical experience. She previously served as CEO of Chroma Medicine, CRDO at Obsidian Therapeutics, EIR at Atlas Venture, and CMO at Sarepta Therapeutics, and holds an MD from the University of Chicago and an MS in epidemiology from the University of Washington.

Eric Blatte· Venture Partner· Cambridge

Eric Blatte joined F-Prime Capital as a Venture Partner in 2021, where he focuses on executive leadership and go-to-market functions in technology and cybersecurity companies. He has founded and helped lead companies from startup to over $100 million in revenue, including RiskRecon (acquired by Mastercard), Trusteer (acquired by IBM), Imprivata (IPO), and Centra Software (IPO). He holds an undergraduate degree from the Wharton School at the University of Pennsylvania and an MBA from MIT Sloan.

Gordon Chen· Venture Partner

Harlan Krumholz· Venture Partner

Jay Farber· Venture Partner· San Francisco, Californiain 𝕏

Jessica Chen· Venture Partner

John Vigeant· Venture Partner

Jon Gelsey· Venture Partner

Josh Feinblum· Venture Partner· Boston, Massachusettsin 𝕏

Julia McDowell· Venture Partner· Providence, Rhode Island, United Statesin

Julia McDowell is a Venture Partner at F-Prime Capital. She has worked as a healthcare investor and executive in both the private and public sectors, with experience in operations, strategy, and commercialization.

Michael Zheng· Venture Partner

Mihir Shah· Venture Partner

Muz Mansuri· Venture Partner· Concord, Massachusetts, United Statesin

Namandjé N. Bumpus· Venture Partner

Nicholas Haining· Venture Partner

Richard Pazdur· Venture Partner

Sam Bisbee· Venture Partner· Boston, Massachusettsin 𝕏

Sam Bisbee serves as Vice President of Information Security at DraftKings Inc. He has held senior technology and cybersecurity roles across multinational enterprises, startups, and B2B SaaS companies, and provides advisory services to enterprise leaders, investors, and startups.

Sandor Palfy· Venture Partner· Budapest, Hungaryin 𝕏

Stephanie Robotham· Venture Partner

Steve Johnson· Venture Partner

Thomas Beck· In Memoriam

Mona Vernon· Venture Partner· Boston, Massachusetts𝕏

Tristan Zajonc· Venture Partner· San Francisco, Californiain 𝕏

Tristan Zajonc is cofounder and CEO of Continual, an AI agent platform for business. Previously, he cofounded Sense, a data science and machine learning platform acquired by Cloudera in 2016, where he subsequently led the ML engineering team for three years. His earlier career included ten years in applied data science roles with organizations including USAID, the World Bank, and Harvard University's Institute for Quantitative Social Science, and he holds a PhD from Harvard University.

Abby Wagner· Senior Accountant· Cambridgein

Abby Wagner joined F-Prime Capital in September 2024 as a Senior Accountant. She previously worked as an Assurance Senior at Ernst & Young, LLP, focusing on private clients in the wealth and asset management industry. She holds an MBA and a BS in Accounting with a minor in Finance from Auburn University.

Abdul Abdirahman· Senior Associate· Boston, Massachusettsin 𝕏

Abdul Abdirahman is a Principal at F-Prime Capital, concentrating on early-stage B2B software and fintech investments. Before F-Prime, he invested in emerging markets technology startups and worked with a venture-backed digital banking and payments startup in East Africa. He started his career in financial services, providing assurance and valuation work for venture capital, private equity, and hedge funds in New York and London, and holds B.A. and B.S. degrees from the University of Minnesota along with joint MBA and MPA/ID degrees from Stanford's Graduate School of Business and the Harvard Kennedy School.

Allan Galper· Vice President & Associate General Counsel· Cambridge

Allan Galper serves as Vice President & Associate General Counsel at Fidelity Investments and supports F-Prime on legal matters spanning portfolio company investments and exits, fund formation, fund administration, and management company operations. He has over 25 years of legal experience across biotech, healthcare, software, and financial services, and previously was a partner at McCarter & English and an associate at Willkie Farr & Gallagher.

Andrew Bognanni· Director of Finance· Cambridge

Andrew Bognanni joined F-Prime in April 2022 to support the firm's finance and operations teams. He previously worked as a Manager at Standish Management and in the audit practice at RSM, and holds an M.S. in Accounting from Northeastern University.

Cathy Wong· Senior Director of Finance· Cambridgein

Cathy Wong joined F-Prime as Senior Director of Finance in July 2023, bringing over 14 years of accounting and finance experience. She previously served as a Controller at THL and held accounting and tax roles at Blackstone, Bain Capital, Bain & Company, and PwC. She holds a B.S. in Business Administration from Boston University and is a licensed CPA in Massachusetts.

Chance Mathisen· Associate· Cambridgein

Associate at F-Prime focused on early-stage enterprise software investments. Previously a consultant in Accenture's Software & Platforms Strategy practice, advising hyperscalers and technology companies on go-to-market and market expansion. Holds a B.S. in Managerial Economics from UC Davis.

Christine D'Attilio· Executive Assistant

Claire Knowlton· Marketing Associate· Cambridgein

Claire Knowlton joined F-Prime in 2025 as a Marketing Associate, supporting marketing through event planning and internal communications. She previously worked in email and social media marketing at an estate planning law firm and holds a BA in Marketing from Loyola University Chicago.

Clay Basser-Wall· Chief Compliance Officer· Cambridgein

Clay Basser-Wall is F-Prime's Chief Compliance Officer with over 20 years of legal and compliance experience. He joined F-Prime in 2020 after roles at Fidelity's Ethics Office, the U.S. SEC as an enforcement attorney, and law firms Wilson Sonsini and Brobeck Phleger & Harrison.

Crissy Derome· Executive Assistant· Cambridge

Crissy Derome joined F-Prime Capital in 2024, supporting the Crypto team, and serves as Project Coordinator for Fine Structure Ventures managing executive operations and scheduling. She previously held senior administrative roles at Fidelity Investments, Devonshire Investors, and Shields Health Care Group, and holds a Paralegal Studies degree from Eastern Nazarene College.

Davina Magargal· Head of Marketing· Cambridgein

Davina Magargal is F-Prime's Head of Marketing, overseeing brand strategy, communications, and marketing, with over 20 years in venture capital. She previously handled investor communications at Excel Venture Management and led marketing at Globespan Capital Partners and JAFCO Ventures, and holds a BA from Cedar Crest College.

Debbie Griffin· Chief Financial Officer· Cambridgein

Debbie Griffin is CFO at F-Prime with over 25 years of experience, overseeing finance and administration for Life Sciences and Fine Structure Ventures. She first joined F-Prime in 2013 for a decade in various finance roles, later served as CFO at Human Capital, and rejoined F-Prime in April 2026. She previously held accounting roles at Devonshire Investors, CFGI, and Ernst & Young.

Derrick Williams· Receptionist· Cambridgein

Derrick Williams is the Receptionist at F-Prime, joining in October 2018. He previously spent five years in security with Northeast Security and studied Computer Networking Operations at Gibbs College.

Eleni Russell· Senior Director of Finance· Cambridgein

Eleni Russell is Senior Director of Finance at F-Prime, which she joined in 2018, and has more than 15 years of experience in venture capital and private equity. She previously worked as an Accounting Manager at Fidelity Investments, overseeing venture capital and private equity entities within the Corporate Accounting group, and earlier as a senior accountant at TVM Capital. She holds a Bachelor of Science in Finance from Suffolk University.

Elizabeth Lamb· Executive Assistant· Cambridge

Elizabeth Lamb is an Executive Assistant at F-Prime Capital Partners, which she joined in July 2025 before moving into a full-time role in March 2026 supporting several members of the team. She previously held Executive Assistant positions at startups and pharmaceutical companies including Kura Oncology, GNS Healthcare, and Vertex, and spent 17 years in the Legal Department at Fidelity Investments. She earned an AS in Computer Programming and an AA in Liberal Arts from Keene State College.

Erica Lee· Principal· Cambridgein

Erica Lee is a Principal at F-Prime, where she focuses on investments in healthcare technology and services companies. She joined the firm in 2021 after working as an investment banking associate at Bank of America Merrill Lynch, advising on IPO and M&A transactions in healthcare IT. She holds a B.A. in Finance and International Business from Georgetown University.

Garth Rapeport· Entrepreneur-in-Residence

Grace Root· Director of Finance

Henry Trapnell· Director of Industry Networks· Birmingham, Alabama, United Statesin

Henry Trapnell is Director of Industry Networks at F-Prime Capital, where he leads a global community of executives and supports the firm's understanding of corporate strategic priorities in AI adoption, fintech, and enterprise software. He holds an MBA from Stanford and previously worked at Google and JP Morgan.

Jack Neureuter· Senior Associate· United Statesin

Jillian Enos· VP of Finance

Jingwei Li· Senior Associate· New York, New York, United States

John Shiver· Special Advisor

Joshua Gray· Vice President and Associate General Counsel· Boston, Massachusetts, United Statesin

Karen Roaf· Director of Human Resources

Kendra Ryan· Director of Ecosystem Network

Laura Wysk· Executive Assistant

Liam Maniscalco· Associate

Lisa Robidoux· Senior Accountant· Greater Bostonin

Lucia Del Guerzo· Office Manager

Martin Taylor· Senior Associate· Londonin

Martin Taylor is a Principal at F-Prime Capital focused on company building and early-stage venture capital investment in biotechnology. He has served on the founding or operational teams of five portfolio companies and holds particular interest in oncology, cardiovascular, renal, metabolic, and rare disease therapeutics. He holds a First Class BA and MSci from the University of Cambridge and a PhD from the Cancer Research UK London Research Institute and UCL, with an academic background in molecular biology, biochemistry, biophysics, and genetics.

m•••@fprimecapital.comreveal

Megan Jenkins· Senior Director of Finance· Boston, Massachusetts, United Statesin

Megan Jenkins is Senior Director of Finance at F-Prime Capital, where her work covers financial analysis, strategic planning, and financial operations. Her experience includes fund financial reporting and valuations for venture capital and private equity firms, fund onboarding, investor communications, risk management, and compliance. She is a CPA and holds a Master's in Accounting/MBA and a Bachelor's degree in Mathematics.

Mike Feng· Head of Technology and Data Science· Cambridge, Massachusetts, United Statesin

Natasha Rodgers· Associate

Nicole Creighton· Human Resources Generalist

Nikhil Ananth· Associate· Boston, Massachusettsin 𝕏

Olivia Carlson· Senior Associate· United Statesin

Rachel Feely-Kohl· Vice President, Community & Platform

Rachel Woolbert· Executive Assistant

Raj Basak· Senior Associate· Cambridge, Massachusetts, United Statesin

Raj Basak is a Senior Associate at F-Prime Capital, where he focuses on life sciences and healthcare investing. He previously worked in healthcare investment banking and consulting, and has a background in research.

Renée Beccia· Chief Financial Officer

Robert Weisskoff· Partner· Massachusettsin

r•••@fprimecapital.comreveal

Rosanne Yang· Senior Legal Counsel· United Statesin

Rosanne Yang is Senior Legal Counsel at F-Prime Capital, where she advises private equity and venture capital investors along with high-growth companies on transactions and other legal matters. Her work spans venture financings, mergers and acquisitions, capital markets, corporate governance, due diligence, and commercial agreements, with a focus on the technology and life sciences industries. She has held both in-house and law firm roles.

Rosy Howell· Executive Assistant· Washington, District of Columbia, United States

Sarah Alvarez· Executive Assistant

Sarah Lamont· Investor· Boston, Massachusettsin 𝕏

Sarah Lamont is an investor at F-Prime focusing on early-stage fintech companies. She can be reached at slamont@fprimecapital.com.

Shervin Ghaemmaghami· Investor· Cambridge, Massachusettsin 𝕏

Stacie Weninger· Venture Partner· Massachusettsin

Stephen Knight· President and Managing Partner· Cambridge, Massachusettsin

Stephen Knight is a Yale-trained MD/MBA physician-investor with Bell Labs and NIH roots and biotech operating experience who co-founds platform companies and works with academics to spin out science.

s•••@fprimecapital.comreveal

Tenzin Jampa· Data Scientist· New York, New York, United Statesin

Tenzin Jampa is a Data Scientist at F-Prime and a graduate of MIT in Physics and Philosophy. As an undergraduate researcher, Jampa built a deep learning pipeline to classify particles from CERN LHCb collision data, developed benchmarking frameworks for semantic retrieval over physics literature, and created an open-source symbolic algebra library in Python, with additional work fine-tuning domain-specific language models such as PhysBERT and integrating knowledge graphs into Retrieval-Augmented Generation systems. Jampa also writes essays and hosts podcasts on technical and philosophical topics.

Bryan Sheehan· Data Scientist· San Franciscoin

b•••@headline.comreveal

Crissy Derome· Administrative Project Coordinator· Bostonin

Crissy Derome is a Project Coordinator at Fine Structure Ventures, where she supports the venture capital team's operations and projects. She previously held senior administrative roles at Fidelity Investments and Devonshire Investors, supporting executives across Corporate Development, Fidelity Labs, and Asset Management, and earlier spent over a decade at Shields Health Care Group leading administrative operations. She holds a degree in Paralegal Studies from Eastern Nazarene College and is a certified Notary Public in Massachusetts.

David Needell· Senior Associate· Bostonin

David Needell is a Senior Associate at Fine Structure Ventures, where he focuses on technology and teams in the aerospace, computing, and climate markets. He holds an undergraduate degree in Mathematics and Physics from Bowdoin College and a PhD from Caltech, where he worked on next-generation solar photovoltaic light concentrators and co-founded a startup with Professor Harry Atwater to integrate the devices into commercial windows. He later did postdoctoral research at Columbia University on two-dimensional materials for spin-wave and quantum computing applications.

d•••@finestructure.vcreveal

Jeb Miller· Chief Compliance Officerin

Jeb Miller is a General Partner at Icon Ventures, which he joined in 2009, with over 25 years of experience across venture capital, operating roles, and investment banking. His earlier career included co-founding Morgan Stanley Technology Ventures in 2001, partner and principal roles at ComVentures and Worldview Technology Partners, technology investing at The Carlyle Group, a business development role at Internet consultancy Scient, and technology investment banking at Morgan Stanley. He holds a Bachelor of Arts in economics from Harvard College.

j•••@iconventures.comreveal

Mario Pérez· Senior Legal Counsel· New York, New York, United Statesin

Michelle Alfano· Chief Financial Officer· Birmingham, Alabama, United Statesin

Rodrigo Prudencio· Senior Associate· Seattle, Washington, United Statesin

Rodrigo Prudencio is Managing Partner at Propeller, a climate fund focused on ocean-based and ocean-proximate industries. He has more than 25 years of experience in venture capital investing across clean energy, climate, and sustainability, and spent nearly seven years on Amazon's Global Corporate Development team, where he led investments for the Climate Pledge Fund and ran the Alexa Accelerator and Next Stage programs for the Alexa Fund. He also founded Amazon Corporate Development's diversity, equity, and inclusion efforts.

r•••@propellervc.comreveal

Tobias Egle· Senior Associate· Cambridge, Massachusettsin 𝕏

Tobias Egle is a Senior Associate at Fine Structure Ventures, where he leads investments in next-generation computing, advanced materials, aerospace, and climate. He previously invested in early-stage startups focused on semiconductors and AI datacenter infrastructure at M Ventures, the corporate VC arm of Merck KGaA. He earned a PhD in Materials Science & Mechanical Engineering and an M.Sc. in Applied Physics from Harvard University, and holds M.Sc. and B.Sc. degrees in Chemical & Process Engineering from the Karlsruhe Institute of Technology.

Founder mafia

The F-Prime Capital mafia →

7 people who came through F-Prime Capital went on to found or lead other companies.

Miles LasaterVenture PartnerFounded Purpose Built Ventures Studio +2 Wei LiSenior AssociateFounded Quantxbio +1 Bobby GasparVenture Partner, MD, PhDFounded Orchard Therapeutics Carlos BustamanteVenture Partner, PhDFounded Galatea Bio Rodrigo PrudencioSenior AssociateFounded Shuddle Nate FoxVenture Summer AssociateFounded Ribbon Health David Mou MD MBAInternFounded Benchmarkhealth

What they invest in

from 294 of 445 portfolio companies

Healthtech ×138Biotech ×114Digital Health ×74AI & Machine Learning ×73Medical Devices ×71SaaS ×68Fintech ×61Enterprise Software ×44

HQs:United States×185India×12China×11United Kingdom×10Switzerland×3Japan×3

Who they back

founder profiles across 199 portfolio companies

41%

solo founders

82 of 199 mapped founding teams

43%

repeat founders

of 236 founders with career history

~4 yrs

old at investment

median across 92 dated deals

Founding team size:solo founder×822 founders×793 founders×214+ founders×17

Where their founders studiedfrom 220 founders with education data

Massachusetts Institute of Technology ×15Harvard University ×14The Wharton School ×11University of California, Berkeley ×10Stanford University ×8Harvard Business School ×7Columbia University ×6Northwestern University ×6

What their founders studiedfrom 211 founders with field-of-study data

Computer Science ×53Engineering ×43Life Sciences ×31Business & Management ×29Economics ×22Medicine ×20Finance & Accounting ×18Physics ×16

Where their founders worked beforefrom 236 founders with career history

Massachusetts General Hospital ×8Goldman Sachs ×6McKinsey & Company ×6IBM ×5Stanford University ×5Yale University ×5ConsenSys ×4Uber ×4

Accelerator rootsportfolio companies that came through a program

Y Combinator ×16 Techstars ×6

55 founders hold a PhD · 43 hold an MBA (of 223 with degree data) · backed the same founder in 2+ companies: 2 founders

Investments · 445 tracked

founders shown can be your intro path

By year:2026 · 9 2025 · 10 2024 · 19 2023 · 29 2022 · 20 2021 · 15 2020 · 11 2019 · 13 2018 · 7 2017 · 8 2016 · 5 2015 · 5161 dated

Caribou Biosciencescariboubio.com in 𝕏NASDAQ: CRBUMar 2021

Caribou Biosciences is a clinical-stage biopharmaceutical company developing CRISPR genome-editing therapies, including off-the-shelf CAR-T cell therapies for hematologic malignancies and armored cell therapies using its Cas12a chRDNA platform.

BiotechMedical DevicesBerkeley, US

Jennifer Doudna(Co-founder)Rachel Haurwitz(President and Chief Executive Officer, Co-founder)inMartin Jinek(Co-founder)Andrew May(Executive Officer)

BoardJenny Rooke(Director)in

Board seat Robert Weisskoff· per SEC Form D

Co-investorsAliment Capital Avego BioScience Capital IA Seed Ventures Mission Bay Capital Mission Biocapital Pontifax AgTech +2 more

Neumora Therapeuticsneumoratx.com in 𝕏NASDAQ: NMRASeries A · Jan 2023 · $400M

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

Board seat Stacie Weninger· per SEC Form D

Co-investorsARCH Venture Partners Catalio Capital Management, LP K2 HealthVentures Mercury Fund Premier Partners SoftBank Vision Fund +3 more

peerTransferNASDAQ: FLYWFeb 2020

Flywire operates a global payments platform and software company that processes high-value transactions for education, healthcare, travel, and business-to-business sectors, combining invoicing, settlement tools, and local payment methods across 240+ countries and 140+ currencies to help organizations optimize their accounts receivable functions.

Boston, US

Michael Massaro(Executive Officer, Director)Robert Orgel(President and Chief Operating Officer)Cosmin Pitigoi(Chief Financial Officer)Patrick Blanc(Chief Technology Officer)Peter Butterfield(General Counsel and Chief Compliance Officer)Mohit Kansal(Chief Payments Officer)

Board seatDavid Jegen· per SEC Form D

Co-investorsGoldman Sachs Kfund Spark Capital

ShouTi Inc.NASDAQ: GPCRJan 2022SEC filingmedium confidence

ShouTi Inc. is a clinical-stage biopharmaceutical company developing oral small molecule drugs targeting G-protein coupled receptors to treat chronic diseases including obesity, type 2 diabetes, and cardiovascular conditions.

BiotechSouth San Francisco, US

Raymond Stevens(Director)Ramy Farid(Director)Jessica Lifton(Director)Ting Xie(Director)Daniel Auerbach(Director)Cuiping Gu(Director)

Board seat Robert Weisskoff· per SEC Form D · $7M raise · filed Jan 2022

Co-investorsBiotechnology Value Fund

Xilio Therapeuticsxiliotx.com inNASDAQ: XLOJan 2021

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.

BiotechHealthtechWaltham, US

René Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)in Katarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsBain Capital Life Sciences Bay City Capital M Ventures MRL Ventures Fund RA Capital RiverVest Venture Partners +9 more

Aclaris Therapeuticsaclaristx.comNASDAQ: ACRSSeries A · Oct 2012 · $21M

Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.

BiotechHealthtechMedical DevicesWayne, US

Neal Walker(Executive Officer, Director)Kamil Ali-Jackson(Executive Officer)Stuart D. Shanler(Executive Officer)inJoseph Monahan(Executive Officer)in Hugh Davis(Executive Officer, Director)inJames Loerop(Executive Officer)

Co-investorsAisling Capital APERTURE Venture Partners Foresite Capital RA Capital Sofinnova Ventures Sofinnova Venture Partners +1 more

Adageneadagene.com inNASDAQ: ADAG

Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment.

AI & Machine LearningBiotech

Co-investorsEight Roads Ventures Toba Capital General Atlantic

Adaptimmuneadaptimmune.com in 𝕏OTC: ADAPYSep 2014

Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.

BiotechHealthtechMedical DevicesAbingdon, Oxfordshire, US

James Noble(Chief Executive Officer)Adrian Rawcliffe(Chief Executive Officer and Director)in Gavin Wood(Chief Financial Officer)in William Bertrand(Chief Operating Officer)in John Lunger(Chief Patient Supply Officer)inElliot Norry(Chief Medical Officer)in

Co-investorsAvoro Capital Advisors Eight Roads Ventures Foresite Capital New Enterprise Associates (NEA)Ridgeback Capital

Avalyn Pharma Incavalynpharma.com inNASDAQ: AVLNSep 2023 · $175M

Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.

BiotechHealthtech

Lyn Baranowski(CEO)in

Co-investorsAndera Partners Catalio Capital Management, LP InVivium Capital Norwest Venture Partners RiverVest Venture Partners SR One Capital Management +9 more

Beam Therapeuticsbeamtx.com in 𝕏NASDAQ: BEAMNov 2018

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.

BiotechDeep TechMedical DevicesCambridge, US

David R. Liu(Founder and Inventor)inJ. Keith Joung(Founder and Inventor)inFeng Zhang(Founder and Inventor)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)

Co-investorsARCH Venture Partners Dreamers VC Eight Roads Ventures Foresite Capital GV (Google Ventures)HongShan Capital Group +1 more

Bicara Therapeuticsbicara.com in 𝕏NASDAQ: BCAXSeries B · Mar 2023 · $110M

Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors.

Ivan Hyep(Chief Financial Officer and Treasurer)inLara Meisner(Chief Legal Officer, Compliance Officer and Corporate Secretary)in David Raben(Chief Medical Officer)in

Co-investorsAisling Capital Eight Roads Ventures Foresite Capital Premji Invest RA Capital Red Tree Venture +5 more

Coherus Biosciencescoherus.com in 𝕏NASDAQ: CHRS

Coherus Oncology develops and commercializes immuno-oncology therapies, including the approved LOQTORZI, to treat patients with cancer.

BiotechHealthtechMedical DevicesRedwood City, US

Dennis M. Lanfear(Executive Officer, Director)Denny Lanfear(Founder)inAlan C. Herman(Executive Officer)inJean-Frederic Viret, Ph.D.(Executive Officer)Peter K. Watler, Ph.D.(Executive Officer)Barbara K Finck, M.D.(Executive Officer)

Co-investorsHEALTHCARE ROYALTY PARTNERS Sofinnova Ventures Venrock

Coinbasecoinbase.com in 𝕏Nasdaq: COIN

Coinbase is a cryptocurrency exchange platform that offers trading, custody, and financial services for cryptocurrencies, stocks, derivatives, and prediction markets to consumers, institutions, and developers.

Crypto & Web3FintechSan Francisco, US

Brian Armstrong(Co-founder & CEO)in Fred Ehrsam(Co-founder)in Emilie Choi(President & COO)in Alesia Haas(Chief Financial Officer)in Paul Grewal(Chief Legal Officer & Secretary)inLawrence (L.J.) Brock(Chief People Officer)

Co-investors1confirmation A.Capital Ventures a16z crypto Acrew Capital Andreessen Horowitz Ansa Capital +54 more

Compass Therapeuticscompasstherapeutics.com in 𝕏NASDAQ: CMPXDec 2017

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

Schuetz Thomas(Executive Officer, Director)in Errik Anderson(Executive Officer, Director)in Thomas J. Schuetz(Executive Officer, Director)inVered Bisker-Leib(Executive Officer)inBarry Shin(Chief Financial Officer)in Neil Lerner(Senior Vice President, Chief Accounting Officer)in

Co-investorsBioBrit Foresite Capital OrbiMed venBio Partners Vivo Capital Borealis Ventures +1 more

Cytek Biosciencescytekbio.com in 𝕏NASDAQ: CTKBOct 2020

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets.

BiotechDeep TechHardwareHealthtechMedical DevicesBellevue, US

Wenbin Jiang, Ph.D.(CEO and Chairman of the Board)Wenbin Jiang(Executive Officer, Director)inMing Yan, Ph.D.(Chief Technology Officer)Ming Yan(Executive Officer, Director)inJiecheng Zhang(Director)Allen Poirson(Director)

Co-investors3E Bioventures Capital Northern Light Venture Capital RA Capital

Denali Therapeuticsdenalitherapeutics.com inNASDAQ: DNLISeries A · Feb 2024 · $220M

Denali Therapeutics develops therapeutics for neurodegenerative diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Marc Tessier-Lavigne(Director)inRyan Watts(Executive Officer, Director)inAlexander O. Schuth(Executive Officer)inRyan J. Watts(President, Chief Executive Officer and Director)inCarole Ho(Executive Officer)inSteve E. Krognes(Director)in

Co-investorsARCH Venture Partners EcoR1 Capital Foresite Capital ARCH Venture Flagship Pioneering Flagship Ventures +1 more

FLYWIREflywire.com in 𝕏NASDAQ: FLYW

Flywire is a global payments platform and software company that enables complex international payments across education, healthcare, travel, and B2B sectors.

Enterprise SoftwareFintechSaaSBoston, US

Iker Marcaide in Mike Massaro(CEO)in

PartnerDavid Jegen· led

Co-investors500 Global Accel Bain Capital Ventures Balderton Capital Boston Seed Capital Cota Capital +7 more

Insmedinsmed.com in 𝕏NASDAQ: INSM

Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.

BiotechDigital HealthHealthtechMedical Devices

Will Lewis(Chair and Chief Executive Officer)inGeoffrey AllaninSara Bonstein(Chief Financial Officer)inRoger Adsett(Chief Operating Officer)Martina Flammer(Chief Medical Officer)in S. Nicole Schaeffer(Chief People Strategy Officer)in

Co-investorsBessemer Venture Partners Foresite Capital OrbiMed Prospect Venture Partners NVIDIA

Precision BioSciencesprecisionbiosciences.com in 𝕏NASDAQ: DTIL

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

DEREK JANTZ(Executive Officer, Director)inMATTHEW KANE(Executive Officer, Director)Jeff Smith(Co-founder)in Derek Jantz(Co-founder)inTODD MELBY(Executive Officer)in Michael Amoroso(President, Chief Executive Officer)in

Co-investorsage1 Agent Capital Aliment Capital Brace Pharma OCV Partners OUP (Osage University Partners)+4 more

Prime Medicineprimemedicine.com in 𝕏NASDAQ: PRMESeries A · Oct 2019 · $120M

Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R.

BiotechDeep TechHealthtechMedical Devices

Andrew Anzalone(Co-founder and Head of Platform)in David Liu(Co-founder)inAllan Reine(Chief Executive Officer)in Mohammed Asmal(Chief Medical Officer)inAnn Lee(Chief Technical Officer)inSvetlana Makhni(Chief Financial Officer)in

Co-investorsARCH Venture Partners GV (Google Ventures)Newpath Partners OUP (Osage University Partners)Samsara BioCapital Arrive

Rallybio, LLCrallybio.com in 𝕏NASDAQ: RLYB

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)

Co-investors5AM Ventures Canaan Partners Connecticut Innovations Mitsui Global Investment Solasta Ventures Pivotal Life Sciences

Toasttoasttab.com inNYSE: TOST

Toast provides a restaurant management platform combining point-of-sale hardware (Flex POS, Toast Go 3 handheld) with software tools for online ordering, payroll, and other operations.

FintechFoodTechRetail TechSaaSBoston, US

Stephen Fredette(Executive Officer, Director, Promoter)Jonathan Grimm(Director, Promoter)inAman Narang(Director, Promoter)inChristopher Comparato(Executive Officer, Director)

BoardSteve Papa(Director, Promoter)

PartnerDavid Jegen· led

Co-investorsBessemer Venture Partners Evolution VC Partners Glynn Capital Management Mastry Riot Ventures Teamworthy Ventures +2 more

Unum Therapeuticscogentbio.com in 𝕏NASDAQ: COGT

Cogent Biosciences is a biotechnology company developing small molecule precision therapies for genetically driven diseases where the cause is linked to a specific genetic mutation.

BiotechDigital HealthHealthtechLongevityMedical DevicesCambridge, US

Charles Wilson(Executive Officer, Director)Christiana Stamoulis(Executive Officer)inAndrew Robbins(Chief Executive Officer, President and Director)inJohn Green(Chief Financial Officer)inEvan Kearns(Chief Legal Officer and Corporate Secretary)inCole Pinnow(Chief Commercial Officer)in

Co-investorsAtlas Venture

小马智行 (NASDAQ: PONY)pony.ai in 𝕏NASDAQ: PONY

Pony.ai develops autonomous driving technology and systems for multiple applications including robotaxis, robotrucks, and personally owned vehicles, serving both everyday mobility and commercial logistics markets.

AI & Machine LearningMobility & TransportationRoboticsSilicon Valley, US

James Peng(Founder)inTiancheng Lou(Founder)in

Co-investorsComcast Ventures DCM Ventures Morningside Venture Capital Limited Legend Capital Puhua Capital

Eywa Pharmaeywapharma.sg✓ verified

Eywa Pharma develops and manufactures generic drugs across multiple therapeutic areas and dosage forms, including tablets, capsules, and oral suspensions, for patients and pharmacies.

Advanced ManufacturingBiotechHealthtechMedical DevicesSingapore, SG

Board Ketan Patel(Director)in

F-Prime Capitalfprimecapital.com✓ verified

Beam Therapeutics develops CRISPR base editing technology to create precision genetic medicines for treating human diseases.

BiotechDeep TechEnterprise SoftwareFoodTechMedical DevicesSaaSBoston, US

John Evans(CEO)

Co-investorsASTUTIA Ventures GmbH Golden Sparrow Ventures, Llc Arthur Ventures Brevan Howard Digital Kaiser Permanente Ventures White Star Capital

Leyden Labsleydenlabs.com inSeries A · Mar 2021 · $47M✓ verified

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.

BiotechDeep TechHealthtechLeiden, NL

Koenraad Wiedhaup(Founder & Chief Executive Officer)in Ronald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)in Dinko Valerio(Founder and Chair of the Supervisory Board)in Jintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in

Co-investorsClavystBio GV (Google Ventures)Bluebird Ventures Casdin Capital European Innovation Council Fund European Investment Bank +6 more

Nflection Therapeuticsnflection.com inJul 2023✓ verified

NFlection is a biopharmaceutical company developing novel therapeutics.

BiotechMedical DevicesBoston, US

Christopher Powala(Chief Development Officer, Former President & CEO)Mark de Souza(Executive Officer, Director)in

BoardCorey Goodman(Director)Ketan Patel(Director)in

Co-investorsvenBio Partners venBio Global Strategic

OrsoBioorsobio.com in 𝕏✓ verified

OrsoBio develops therapies to restore energy homeostasis in patients with severe metabolic disorders, drawing on biological research including human liver organoids and insights from metabolic pathways.

BiotechDeep TechMedical DevicesMenlo Park, US

Mani Subramanian(Executive Officer, Director)inGangadhara Ganapati(Executive Officer, Director)Dr. SubramanianDr. Myers

Board Matthew Young(Director)inSrinivas Akkaraju(Director)

Co-investorsAscenta Capital Longitude Capital Samsara BioCapital

1Uphealth1up.health in 𝕏Series B · Apr 2023 · $25M

1upHealth provides a FHIR-first health data platform that helps health plans and payers acquire, manage, and exchange healthcare data, including automating prior authorization, member data access, and provider directories.

Data & InfrastructureDigital HealthHealthtechBoston, US

Ritwik Sahu(Executive Officer, Director)Ricky Sahu(Founder)inJoseph Gagnon(Director)

Board Victor Echevarria(Director)inDavid Jegan(Director)T. Scott Law, Jr.(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsEniac Ventures Jackson Square Ventures Meridian Street Capital Sixth Street Social Leverage

Affinia Therapeuticsaffiniatx.com inSeries A · Oct 2025 · $60M

Affinia Therapeutics develops genetically engineered adeno-associated virus (AAV) therapies for treating genetic diseases, focusing initially on cardiovascular and central nervous system conditions.

AI & Machine LearningBiotechDeep TechWaltham, US

Luc Vandenberghe(Director)Aaron Tward, M.D., Ph.D.(Scientific Co-Founder)Botond Roska, M.D., Ph.D.(Scientific Co-Founder)Luk Vandenberghe, Ph.D.(Scientific Co-Founder and Adviser, and Board Member)Rami Daoud(Executive Officer)inRick Modi(Chief Executive Officer, Board Member)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsAtlas Venture EcoR1 Capital Eight Roads Ventures GV (Google Ventures)New Enterprise Associates (NEA)TCG Crossover +1 more

Antlia Bioscience, Inc.antliabio.com inJun 2026SEC filingmedium confidence

Antlia Bioscience develops long-acting therapeutics aimed at treating chronic cardiometabolic diseases.

BiotechEncinitas, US

Brian Laurence Johnson(Executive Officer, Director)Ankit Mahadevia(Executive Officer, Director)

BoardBen Auspitz(Director)Carlos Garcia Echeverria(Director)

Board seat Martin Taylor Nihal Sinha· per SEC Form D · $20M raise · filed Jun 2026

Buoy Healthbuoyhealth.com in 𝕏Nov 2020

Buoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers.

AI & Machine LearningDigital HealthHealthtechBoston, US

Andrew Le(Executive Officer, Director, Promoter)in Andrew Le, MD(Founder)inAdam Lathram(Executive Officer, Director, Promoter)Jose Eduardo Reyes(Director)Nathanael Yu Ren(Director)

Board seatCarl Byers· per SEC Form D

Co-investorsEvolution VC Partners Torch Capital FundRx Humana Optum Ventures Trustbridge Partners +1 more

CHARM Therapeuticscharmtx.com inSeries A · Apr 2023 · $50M

CHARM is a biotech company developing a next-generation menin inhibitor for acute myeloid leukemia (AML), designed to address resistance seen with first-generation approaches.

AI & Machine LearningBiotechHealthtechLondon

Lakshyaditya Singh Aithani(Executive Officer, Director)

BoardRishi Gupta(Director)in Muzammil Mansuri(Director)inGary Glick(Director)in

Board seat Muz Mansuri Nihal Sinha· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)OrbiMed SR One Capital Management Axial VC Khosla Ventures NVentures

Comanche Biopharmacomanchebiopharma.com inJan 2024 · $75M

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women.

BiotechFemTechHealthtechConcord, US

Mike Young(Founder)inT Scott Johnson(Founder)inPaul Antinori(Executive Officer)Allison August(Executive Officer)inThomas Scott Johnson(Executive Officer, Director)

Board Brendan Bulik-Sullivan(Director)in

Board seat Muz Mansuri Ketan Patel· per SEC Form D

Co-investorsAtlas Venture GV (Google Ventures)Broadview Ventures Lilly Asia Ventures New Enterprise Associates (NEA)

Ensomaensoma.comSeries A · Jan 2023 · $50M

Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.

BiotechHealthtechMedical DevicesBoston, US

Albert Seymour(Director)

Board Kush Parmar(Executive Officer, Director)in Paula Soteropoulos(Director)

Board seat Stephen Knight· per SEC Form D

Co-investors5AM Ventures Aju IB Invesment Corporation Catalio Capital Management, LP Delos Capital Solasta Ventures Alexandria +7 more

Generation Biogenerationbio.comFeb 2018SEC filingmedium confidence

BiotechCambridge, US

Geoff McDonoughy(Executive Officer, Director)Glenn Goddard(Executive Officer)Mark Angelino(Executive Officer)

Board Jason Rhodes(Director)inAnthony Quinn(Director)

Board seat Catherine Stehman-Breen· per SEC Form D · $100.4M raise · filed Mar 2018

Co-investorsAtlas Venture Foresite Capital Invus

Notabenenotabene.id in 𝕏Series A · Jun 2026 · $10.2M

Notabene provides compliance and regulatory technology for crypto businesses and financial institutions, helping them meet regulatory requirements like the FATF Crypto Travel Rule through real-time screening, sanctions checks, and wallet identification.

Crypto & Web3CybersecurityEnterprise SoftwareFintechNew York City, US

Pelle Braendgaard(CEO/ Co-Founder)in Andres Junge(Founder)in Ania Lipinska(Founder)in Alice Nawfal(Founder)in

BoardMatthew Walsh(Director)Peter Johnson(Director)in

Board seatDavid Jegen· per SEC Form D

Co-investorsDigital Currency Group ParaFi Capital Signature Ventures Wintermute Y Combinator Bitso +10 more

OneAdvisoryoneadvisory.co inJul 2025 · $8M

Dispatch is a data orchestration platform for the wealth advisory ecosystem that automatically syncs client data across disparate software tools and integrations.

AI & Machine LearningData & InfrastructureFintechSaaSMiami, US

Robert Nance(Executive Officer, Director, Promoter)Madalyn Armijo(Director, Promoter)

Board Chris Downer(Director)inRafi Lurie(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsExpa Brewer Lane Ventures CoFound Partners Venture Fika Ventures Ritholtz Wealth Management Twelve Below

Rarecyterarecyte.comJul 2023 · $24M

Seattle, US

Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)in Joseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)

Board Robert Shepler(Director)in

Board seat Robert Weisskoff· per SEC Form D

Co-investors5AM Ventures Arboretum Ventures Sofinnova Ventures Telegraph Hill Partners

Real Estate Equity Exchangeunisonim.comMay 2018SEC filingmedium confidence

Unison Investment Management (UnisonIM) is a registered investment adviser that builds and manages institutional equity and credit strategies giving exposure to U.S. residential housing and home price appreciation.

FintechPropTechSan Francisco, US

Thomas Sponholtz(Founder, CEO & Chairman)John Martinez(Director)Edgar Green(Director)James Riccitelli(Executive Officer, Director)Douglas H. Lowrey(Director)Matthew O'Hara(Chief Investment Officer)

Board seatDavid Jegen· per SEC Form D · $40M raise · filed Jun 2018

Snapdocssnapdocs.com in 𝕏May 2021

Snapdocs automates the digital mortgage closing process by connecting lending, settlement, and secondary market teams.

AI & Machine LearningFintechLegalTechPropTechSaaSPortland, US

Aaron King(Founder & Executive Chairman)inMatt Schindel(Executive Officer)Sanam Pangali(Executive Officer)Michael Sachdev(CEO)in

Board Andrew Reed(Director)in

Board seatDavid Jegen· per SEC Form D

Co-investors137 Ventures Accelerator Ventures Alkeon Innovation MetaProp MetaProp Ventures Red Swan Ventures +11 more

Tempest Therapeuticstempesttx.com inSeries B · Feb 2020 · $70M

Tempest Therapeutics is a clinical-stage biotechnology company developing in vivo CAR-T cell therapies for autoimmune and oncology indications.

BiotechHealthtechBrisbane, US

Stephen Brady(Director)inMatthew Angel(Executive Officer, Director)Nicholas Maestas(Executive Officer)inThomas W. Dubensky, Jr.(Executive Officer, Director)Thomas Woiwode(Director)Geoffrey Nichol(Director)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsLAV Lilly Asia Ventures New Enterprise Associates (NEA)Quan Capital Roche Venture Fund Versant Ventures

Threat Stackthreatstack.com inSep 2017

CybersecurityBoston, US

Jennifer M. Andre(Executive Officer)Dustin Webber(Director)Brian Ahern(Executive Officer, Director)in Doug Cahill(Executive Officer, Director)in

BoardChristopher P. Lynch(Director)Maria Cirino(Director)in

Board seatGaurav Tuli· per SEC Form D

Co-investors.406 Ventures fama Ventures, LLC Techstars Accomplice Eight Roads Ventures Scale Venture Partners

Tradiertradier.com inSeries A · Apr 2023 · $24.6M

Tradier offers REST-based APIs and trading platforms providing equity, options, and futures trading, account management, market data, and brokerage services for individual developers and businesses.

FintechSaaSCharlotte, US

Dan Raju(Executive Officer, Director)in Peter Laptewicz(Executive Officer, Director)inRobert Kopple(Director)

BoardAlec Petro(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsDevonshire Investors

Tripsuitetripsuite.com inSeed · Sep 2024 · $5M

TripSuite is a software platform for travel agencies that combines CRM, commission tracking, accounting, itinerary management, analytics, and workflow automation in one system.

SaaSTravel & HospitalityBrooklyn, US

Jacey Jones(Executive Officer, Director, Promoter)inChristopher John Graves(Executive Officer, Director, Promoter)

Board seatGaurav Tuli· per SEC Form D

Viewrayviewray.com in 𝕏Dec 2014

ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment.

HardwareHealthtechMedical DevicesOakwood Village, US

James F. Dempsey(Executive Officer, Director)inDavid Chandler(Mr. Chandler is the Chief Financial Officer of the Issuer.)Chris A. Raanes(Executive Officer, Director)Michael Brandt(Executive Officer)D. David Chandler(Executive Officer)Gregory M. Ayers(President and Chief Executive Officer of the Issuer.)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsAisling Capital OrbiMed

Zenflowzenflow.com in 𝕏Nov 2024

Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.

HealthtechMedical DevicesSan Francisco, US

Shreya Mehta(Founder/CTO)in Nick Damiano(Executive Officer, Director)inJohn Beck(Executive Officer)in

BoardBryan Kim(Director)Blayne Roeder(Director)

Board seat Robert Weisskoff· per SEC Form D

Co-investorsAstia ShangBay Capital LLC Y Combinator Dorm Room Golden Seeds Medical Technology Venture Partners

Zus Healthzushealth.com in 𝕏Mar 2023

Zus provides a platform that removes data waste in healthcare, enabling developers, clinicians, and operators to innovate in patient and care team experience without building underlying infrastructure.

Cloud ComputingData & InfrastructureDigital HealthHealthtechWatertown, US

Jonathan Bush(CEO)inTravis Smith(Executive Officer)in

BoardSteven Fisher(Director)Fay Rotenberg(Director)Julie Yoo(Director)inBenjamin Silver(Director)

Board seatCarl Byers· per SEC Form D

Co-investorsAdvection Growth Capital Alumni Ventures Andreessen Horowitz JAZZ Venture Partners Martin Ventures Maverick Ventures

1Money1moneynetwork.com in 𝕏

1Money builds a decentralized payment network for stablecoin and tokenized deposit transfers, designed for global financial settlements.

Crypto & Web3Fintech

Matt Shroder(Founder)in Brian Shroder(Founder)in

Co-investorsA100X Ventures CMT Digital Ventures Ethereal Ventures Management Ltd.Generative Ventures Hack VC Protagonist +2 more

3F Labs3f.xyz in 𝕏

3F is a DeFi protocol for leveraged strategies on tokenized real-world assets and onchain credit, letting users take leveraged exposure to RWA vaults or deposit stablecoins into Morpho-powered lending vaults to earn yield.

Crypto & Web3Fintech

Romeo Ravagnan(Founder)in

Co-investorsMaven 11 Gate Ventures GSR Metalayer

66 Nao66nao.com

脑动极光 (66nao) develops medical-grade digital therapeutics that combine brain science with AI to assess and treat cognitive impairment caused by vascular disease, neurodegenerative disease, psychiatric disorders, and childhood developmental deficits.

AI & Machine LearningDigital HealthHealthtechMental Health

蔡龙军(首席技术官兼首席运营官、代理首席执行官兼代理首席研发官 (CTO & COO, Acting CEO & Acting CRDO))王俊杰(首席财务官及联席公司秘书 (CFO & Joint Company Secretary))赖知远(市场及运营副总裁 (VP of Marketing and Operations))谭铮(董事会主席、执行董事兼首席战略官 (Chairman & Chief Strategy Officer))

Abk Biomedical Incabkbiomedical.com in 𝕏Series B · Apr 2019 · $30M

ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer.

BiotechHealthtechMedical DevicesHalifax, CA

Robert Abraham(Co-founder (Interventional Radiologist, MD))in Daniel Boyd(Co-founder (Material Scientist))in Sharon Kehoe(Co-founder (Material Scientist))in Anthony Headley(Executive Officer)in Gary Donofrio(Executive Officer)in Michael Mangano(Executive Officer, Director)in

Co-investorsEight Roads Ventures Vivo Capital

Acacia Pharmaeagleus.com inSeries B · Sep 2013 · $24M

Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.

BiotechHealthtechMedical DevicesIndianapolis, US

Co-investorsGilde Healthcare

Adcentrx Therapeuticsadcentrx.com inApr 2023

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology.

BiotechHealthtech

Hui Li(Founder, President & CEO)in

Co-investorsEight Roads Ventures Quan Capital Delta Capital

Adelaadelabio.com in 𝕏Series A · Jun 2021 · $60M

Adela develops blood-based tests for cancer detection using epigenetics and liquid biopsy technology, aimed at helping patients and clinicians detect and act on cancer earlier.

BiotechDigital HealthHealthtechMedical DevicesFoster City, US

Daniel Diniz De Carvalho(Executive Officer, Promoter)Scott Bratman(Executive Officer, Director)in Anne-Renee Hartman(Founder)inAlan Williams(Executive Officer)in Lisa Alderson(Executive Officer, Director)inPriscilla Huang(Executive Officer)in

Co-investorsDecheng Capital OrbiMed Deerfield Management Company Menlo Ventures

Aera Therapeuticsaeratx.com in 𝕏

Aera Therapeutics develops genetic medicines using next-generation delivery technologies and precision payloads optimized for specific diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

Feng Zhang, Ph.D.(Scientific Founder & Board Observer)Akin Akinc, Ph.D.(Chief Executive Officer & Board Director)

Co-investorsARCH Venture Partners Lux Capital GV (Google Ventures)JDRF T1D Fund Newpath Partners

AI biotechowkin.com in 𝕏

Owkin develops AI Scientist, an autonomous AI system that uses biological large language models and multimodal patient data to accelerate drug discovery for pharmaceutical and biotech companies.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSilicon Valley, FR

Thomas Clozel(Co-Founder and Chief Executive Officer)inGilles Wainrib(Co-Founder and Former Chief Scientific Officer)in

Co-investorsBridford Investments (Bridford Group)Cathay Innovation Frst GV (Google Ventures)Alpha Intelligence Capital OTB Ventures +1 more

Albert Inventalbertinvent.com in

Albert provides an operating system for chemists that combines structured data management with AI trained on molecular structures and individual company chemistry datasets.

AI & Machine LearningDeep TechEnterprise Software

Zach Kisner(Co-founder)in Ken Kisner(Co-founder)in Nick Talken(Co-founder)in Neelesh Vaikhary(Co-founder)in Zack Kisner(Founder)in

Co-investorsCapitalG Coatue Management Coral Capital Homebrew Index Ventures General Atlantic

Alderaskalder.com in

A senior care consulting firm serving Greater Boston families since 1993, offering life care management and aging support services with clinical expertise in geriatric social work.

Digital HealthHealthtechLongevityWellness & FitnessBoston, US

Kate Granigan(Clinical Leadership / Founder)in

Alfredalfredpay.io in 𝕏

Alfred Pay provides cross-border payment infrastructure for Latin America, offering virtual local bank accounts, instant multi-currency settlement, and a developer API.

Crypto & Web3FintechSaaS

Diego Yanez(Founder)in

Co-investorsDepartment of XYZ Digital Currency Group Rayo Capital Group Venture Dept.White Star Capital HOF Capital +3 more

Alibabaalibaba.com

Alibaba.com operates a global B2B e-commerce marketplace that connects buyers with suppliers and manufacturers for wholesale products across multiple industries.

AI & Machine LearningB2B MarketplacesE-commerce

Kuo Zhangin

Co-investorsAcross Capital Partners Eight Roads Ventures Granite Asia ICONIQ K2 Global Lead Edge Capital +4 more

Alluvial Financealluvial.financeAcquired

Staking software developer behind the enterprise liquid staking protocol Liquid Collective, acquired by Galaxy Digital in December 2025.

Chicago, US

Matthew R. Leisinger(Executive Officer, Director)Mara Schmiedt(Executive Officer, Director)Evan Weiss(Executive Officer)

BoardMin Teo(Director)

Co-investorsAmbush Capital Coinbase Ventures Fenbushi Capital Figment Nascent Variant Fund

Almanac Healthalmanac.chat in 𝕏Seed · Mar 2026 · $10M

Almanac Health is a clinical AI company that builds Almanac Chat, an evidence-based platform for clinical AI use by clinicians and health systems.

AI & Machine LearningDigital HealthHealthtechDover, US

Cyril Zakka(Executive Officer, Director)

Co-investorsGeneral Catalyst Lightspeed Venture Partners Soma Capital

Alternative Bio Abioabio-x.com in 𝕏

ABio-X is a life sciences incubation platform that creates and invests in biotech and pharmaceutical companies developing innovative medicines and technologies.

BiotechDeep TechHealthtechBoston, US

Co-investorsCBC Group

Amber Therapeuticsamber-tx.com inSeries A · Jun 2024 · $100M

Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.

Medical Devices

Co-investorsIntuitive Ventures Lightstone Ventures New Enterprise Associates (NEA)Oxford Science Enterprises

Amphoraamphoralogistics.com in

Amphora provides logistics services aimed at supporting business growth and operational efficiency.

E-commerceLogistics & Supply ChainSaaS

Joan Tresserras(Founder)inAdrià Cortés(Founder)in

Co-investorsBStartup Baird Capital HBM Healthcare Investments Longitude Capital

AmplifyMDamplifymd.com inMar 2022 · $23M

AmplifyMD offers a virtual care platform with EHR integrations, automation, embedded AI tools, and a network of remote specialists that lets hospitals and health systems expand physician capacity and add specialty services.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSLos Gatos, US

Anand Nathan(Co-Founder & Chief Product Officer)in Meena Mallipeddi(Co-Founder & Chief Executive Officer)inMohan Mallipeddi, MD(Chief Medical Officer)inNijay Patel(Chief Technology Officer)in Kurt Blasena(Chief Commercial Officer)in

BoardStephen K. Klasko(Board of Directors)

Co-investorsForerunner Ventures Greylock Partners Tau Ventures TAU Ventures

Apellisapellis.com in 𝕏

Co-investorsAvoro Capital Advisors Epidarex Capital Keyhorse Capital Sofinnova Ventures Solasta Ventures venBio Partners

AppliedVRappliedvr.io in 𝕏Series A · Mar 2021 · $29M

AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients.

Digital HealthHealthtechMedical DevicesLos Angeles, US

Matthew Stoudt(Co-Founder and CEO)in Josh Sackman(Co-Founder and President)in

BoardDavid Sackman(Chairman)

Co-investorsEntrada Ventures JAZZ Venture Partners Magnetic Ventures Presence Capital Techstars

AppsFlyerappsflyer.com in 𝕏

AppsFlyer's Measurement Suite provides marketing attribution, incrementality, revenue, and optimization measurement across mobile, web, CTV, and PC & console channels.

AdTechAI & Machine LearningData & InfrastructureMarketing TechSaaS

Oren Kaniel(Founder)inReshef Mann(Founder)in

Co-investors10D DTCP Eight Roads Ventures General Atlantic Meta Pitango +2 more

Apreo Healthapreohealth.com inAug 2025

Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function.

BiotechHealthtechMedical DevicesMenlo Park, US

Karun Durgam Naga(Executive Officer, Director)

BoardHanson S. Gifford III(Director)Zack Scott(Director)inMichael A. Carusi(Director)Drew Field(Director)in Dennis McWilliams(Director)in

Co-investorsIntuitive Ventures Lightstone Ventures Norwest Venture Partners

Argyleargyle.com in 𝕏Jan 2022

Argyle provides a verification platform that automates the collection and verification of income, employment, and asset data using consumer-permissioned, real-time data from payroll, banking, and document sources.

Data & InfrastructureFintechNew York, US

Samuel Fishman(Executive Officer, Director, Promoter)Shmulik Fishman(Founder)in Daniel Yanisse(Director)inChristopher Hansen(Executive Officer, Director)

Co-investorsRackhouse Venture Management Lp SignalFire Bain Capital Ventures Socially Financed Socii Capital

Arion Cancer Hospitalarioncare.cn

Arion Care (美中爱瑞) is an oncology-focused hospital in China providing cancer diagnosis and treatment through multidisciplinary team (MDT) consultations and specialized centers for lung, breast, gastrointestinal, gynecologic, urologic, hepatobiliary, lymphoma, neurologic, and other cancers.

Digital HealthHealthtech

Arnatar Therapeuticsarnatar.com in 𝕏

Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics.

AI & Machine LearningBiotechDeep Tech

Dr. Xuehai Liang(Founder)Dr. Yanfeng Wang(Founder & Chief Operating Officer)

Co-investors3E Bioventures Capital Apricot Capital Eight Roads Ventures Gaorong Ventures Legend Star New Alliance Capital

Artemis Healthartemishealth.com in 𝕏Series B · Feb 2019 · $16M

Artemis Health provides data analytics and insights software to U.S. employers, advisors, and payers to optimize health benefits and reduce healthcare costs.

Data & InfrastructureEnterprise SoftwareHealthtechSalt Lake City, US

Grant Gordon(Executive Officer, Director)inDallen Allred(Executive Officer, Director)inDallin Regehr(Executive Officer)in

Board Dalton Wright(Director)inJon Lim(Director)in Ambar Bhattacharyya(Director)

Co-investorsBessemer Venture Partners Kickstart Valence Ventures Maverick Ventures

Arvelle Therapeuticsangelinipharma.ch in

Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.

BiotechConsumerHealthtechZug, CH

Co-investorsAndera Partners H.I.G. Capital H.I.G. HealthBridge Partners BRV Capital Management H.I.G. BioHealth Partners Life Sciences Partners

Ashbyashbyhq.com in 𝕏

Ashby is a recruiting software platform that serves as an applicant tracking system (ATS) and all-in-one hiring management tool for talent teams.

Enterprise SoftwareHR TechSaaSSan Francisco, US

Benjamin Encz(Founder)in Abhik Pramanik(Co-Founder & VP of Engineering)in

Co-investorsAlkeon Innovation DVC SemperVirens Venture Capital Todd and Rahul’s Angel Fund Trail Run Capital Y Combinator +2 more

Astraeusastraeuswealth.com in

Astraeus is an AI-native operating platform for wealth management firms that unifies data across a firm's fragmented systems into a single governed semantic layer and ontology.

AI & Machine LearningFintechSaaS

Asymmetry Financeasymmetry.finance 𝕏

Asymmetry Finance is a decentralized finance protocol that lets users borrow stablecoins (USDaf and AmpUSD) against BTC or stablecoin collateral at customizable fixed interest rates.

Crypto & Web3Fintech

Co-investorsMagnus Capital Silvermine Capital Avon Ventures Castle Island Ventures Ecco Capital gmjp +1 more

Atalantaatalantatx.com in 𝕏Series A · Jan 2021 · $110M

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.

BiotechDeep TechHealthtechMedical Devices

Co-investorsNovartis Venture Fund RiverVest Venture Partners Sanofi Ventures abrdn plc EQT Life Sciences

AvantStayavantstay.com in 𝕏

AvantStay operates a collection of fully furnished, design-forward vacation rental homes in sought-after U.S. destinations, offering short- and long-term stays with amenities like concierge service, Wi-Fi, and smart locks.

B2B MarketplacesFuture of WorkMarketplacesPropTechTravel & HospitalityCulver City, US

Sean Breuner(Executive Officer, Director, Promoter)in Reuben Doetsch(Executive Officer, Director, Promoter)in Jesse Suarez(Executive Officer)inJodi Kessler(Director)

BoardShawn Colo(Director)Eric Wiesen(Director)in

Co-investorsAbstract Ventures Blue Ivy Ventures Bullpen Capital Convivialité Ventures Daft Capital Evolution VC Partners +7 more

AvenCellavencell.com in 𝕏Series B · Oct 2024 · $110M

AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.

BiotechLongevityMedical Devices

Andrew Schiermeier(Chief Executive Officer)in

Co-investorsNovo Holdings Blackstone Life Sciences Eight Roads Ventures NYBC Ventures

AviadoBio Websiteaviadobio.com in 𝕏

AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

BiotechDeep TechDigital HealthHealthtech

Chris Shaw(Co-Founder & Chief Scientific and Clinical Advisor)inDo Young Lee(Co-Founder)Youn Bok Lee(Co-Founder)in Lisa Deschamps(Chief Executive Officer)in Graeme Fielder(Chief Operating Officer)inAlex Bloom(Chief Development Officer)in

Co-investorsAdvent Life Sciences Dementia Discovery LifeArc Ventures Monograph Capital Partners New Enterprise Associates (NEA)

Avidity Nanomedicinesaviditybiosciences.com in

Avidity Biosciences develops Antibody Oligonucleotide Conjugates (AOCs) that combine monoclonal antibody specificity with oligonucleotide precision for targeted delivery of RNA therapeutics to treat rare genetic muscle diseases.

BiotechDeep TechHealthtechMedical Devices

Co-investorsAvoro Capital Advisors Brace Pharma Frazier Life Sciences Moore Venture Partners

Avivomedavivomed.com

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.

BiotechDeep TechHealthtechMedical DevicesRoseville, US

Lynn Elliott(Co-Founder)Mudit Jain(Co-Founder)Paul Mazanec(Chief Executive Officer)inStephen Masson(Executive Officer, Director)

BoardTheresa C. Pappas(Director)Ketan Patel(Director)in

Co-investorsHatteras Venture Partners Treo Ventures, Llc

Axle Healthaxlehealth.com in 𝕏Series A · May 2025 · $10M

Axle Health provides a logistics and scheduling platform for home health care providers that optimizes clinician routing, staffing decisions, and patient coordination through real-time data and predictive forecasting.

AI & Machine LearningDigital HealthHealthtechLogistics & Supply ChainSaaSLos Angeles, US

Adam Stansell(Founder)in

Co-investorsLightbank Rebel Fund TRAC (Third Round Analytics Capital)Y Combinator Pear VC

Beadsbeads-hospice.jp

Beads Hospice operates a residential facility in Japan that provides palliative and end-of-life care for patients with terminal cancer, neurodegenerative diseases, and other specified conditions.

Digital HealthHealthtechLongevityWellness & Fitness福岡市, JP

Co-investorsEight Roads Ventures

Benchlingbenchling.com in 𝕏Series B · Apr 2016 · $15M

Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.

AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US

Sajith Wickramasekara(Founder/CEO)inAshutosh Singhal(Director)Ashu Singhal(Founder)in

Board Miles Grimshaw(Director)in

Co-investorsAlkeon Innovation Andreessen Horowitz Artisanal Ventures Balaji Srinivasan Draper Associates ICONIQ +15 more

Benchscibenchsci.com in 𝕏Series B · Feb 2020 · $22M

BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtechToronto, US

David Qixiang Chen, PhD(Founder)inElvis Wianda(Co-founder & Chief Data Officer)in Liran Belenzon(Co-founder & CEO)in Tom Leung(Co-founder & Chief Science Officer)inDavid Chen(Co-founder)in

Co-investorsInovia Capital Generation Investment Management Gradient Ventures TCV 500 Global Afore Capital +6 more

Better Life Partnersbetterlifepartners.com in 𝕏Series B · Aug 2023 · $27M

Better Life Partners provides same-day medication-assisted treatment for opioid and alcohol addiction, combining counseling, community support, and medication for people in recovery.

Digital HealthHealthtechMental HealthHanover, US

Adam Groff(Executive Officer, Director)inJuliana Ekong(Executive Officer, Director)Myechia Minter-Jordan(Director)Steven Kelly(Executive Officer)

Board Yair Schindel(Director)inJon Lim(Director)in

Co-investorsaMoon .406 Ventures Maverick Ventures

Bioregenbioregenmed.com

BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration.

BiotechMedical DevicesNew MaterialsChangzhou, CN

Co-investorsEight Roads Ventures

Bison Trailsbisontrails.co in 𝕏acquired by Coinbase

Crypto & Web3Developer ToolsFintechSaaSSan Francisco, US

Aaron Henshaw(Director)Joseph Lallouz(Executive Officer, Director)

Board Nicholas Chirls(Director)in

Co-investorsA.Capital Ventures Blockchain Coinvestors Collab+Currency ConsenSys Mesh Homebrew Kleiner Perkins +5 more

Black Ducksynopsys.com in 𝕏Aug 2014

Synopsys provides design automation tools and intellectual property for semiconductor and electronics companies to develop smart, connected devices.

Developer ToolsEnterprise SoftwareSemiconductorsBurlington, US

Doug Levin(Founder)Aart de Geus(Founder)inStephen N. Gregorio(Executive Officer)Philip B. Granof(Executive Officer)William NMN Ledingham(Executive Officer)Norman L. Shipley(Executive Officer, Director)

Co-investorsAsset Management Company Brightspark Ventures Crosslink Capital DataTribe Differential Ventures Francisco Partners +10 more

Blue Rabbitbluerabbit.vet in

Blue Rabbit is an online veterinary pharmacy that integrates with practice management software to automate prescription fulfillment and patient data management.

E-commerceHealthtechMedical DevicesSaaS

Bluebird Kids Healthbluebirdkids.com inSeries A · Mar 2025 · $32M

Bluebird Kids Health provides pediatric care services with a family-centered approach.

Digital HealthHealthtech

Chris Johnson(Founder, Chief Executive Officer)in Rachel Wilson(Co-Founder, Chief Operating Officer)inDr. Michael Glazier, MD(Co-Founder, Chief Medical Officer)Elizabeth Larsen(Co-Founder, Chief of Staff)in

Co-investors.406 Ventures AIF JUXTAPOSE VENTURES

Blueprint Medicinesblueprintmedicines.com in 𝕏

Blueprint Medicines is a biopharmaceutical company that discovers and develops targeted medicines for patients with diseases such as gastrointestinal stromal tumor and other conditions driven by genetic changes.

BiotechHealthtechCambridge, US

Nick Lydon(Director)Christoph S. Lengauer(Executive Officer)inChristine Bellon(Executive Officer)inKyle Kuvalanka(Executive Officer)in

BoardAlexis Borisy(Executive Officer, Director)Daniel Lynch(Director)

Co-investorsForesite Capital Nextech Invest RA Capital

Buoybuoy.money

Buoy provides an embedded finance API for working capital and liquidity management, letting treasury managers request on-demand top-ups when prefunding accounts run low.

FintechSaaS

Dan Kleinbaum(CEO)

Co-investorsTimon Capital FundRx Humana Optum Ventures Trustbridge Partners WR Hambrecht

Burroburro.ai in 𝕏Jan 2024 · $24M

Burro builds autonomous robots for agricultural and outdoor operations that mow, tow, carry, and spray to automate manual labor tasks.

AgTechAI & Machine LearningRobotics

Terry Scott(Founder)in

Co-investorsAsimov Ventures Catalyst Investors Everywhere Ventures Ff Venture Capital NextFab Ventures Radicle Growth +5 more

Cadence Neurosciencecadenceneuro.com inMay 2023 · $26M

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsJAZZ Venture Partners Lumira Ventures Angelini Ventures Iaso Ventures

Canary Technologiescanarytechnologies.com in 𝕏Series A · Feb 2022 · $15M

Canary Technologies provides digital management software for hotels, replacing traditional paper-based administrative and operational workflows used across the hospitality industry.

Enterprise SoftwareSaaSNew York City, US

Harman Narula(Founder)inSJ Sawhney(Founder)in

Co-investors7BC Venture Capital Brighton Park Capital Commerce Ventures DERIVE VENTURES Insight Partners Oyster Ventures +3 more

CandidProcandidco.com in

Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.

ConsumerDigital HealthHealthtechMedical Devices

Nick Greenfield(Co-founder & CEO)in

Co-investorsA-Rod Corp Averin Capital Bessemer Venture Partners Beyond Capital Kube VC Digitalis Ventures +2 more

Canoe Intelligencecanoeintelligence.com in

Canoe Intelligence provides AI-driven software and data infrastructure for alternative investment management, processing capital call notices, distribution notices, and capital account statements from institutional fund managers to deliver real-time visibility into capital flows across trillions in assets under administration.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechSaaS

Jason Eiswerth(CEO)in Noel Calhoun(CTO)in

PartnerDavid Jegen· led

Co-investorsInner Loop Capital Goldman Sachs

Caplin Point Laboratoriescaplinpoint.net in

Caplin Point Laboratories is a pharmaceutical manufacturer that produces ointments, creams, external applications, and other formulations.

Advanced ManufacturingBiotechHealthtechChennai, IN

C.C. Paarthipan(Chairman)Sridhar Ganesan(Managing Director)in

Carestackcarestack.com in 𝕏Apr 2021 · $25M

CareStack is a cloud-based, all-in-one dental practice management software covering scheduling, patient experience, clinical workflows, revenue cycle management, analytics, and compliance.

Digital HealthHealthtechSaaS

Co-investorsAccel Callapina Capital Eight Roads Ventures Steadview Capital

Carrot Fertilityget-carrot.com in 𝕏Jun 2023

Carrot is a global fertility and family-building platform that provides access to fertility care, maternity support, and family-building guidance for individuals and families.

FemTechHealthtechHR TechSan Francisco, US

Asima Ahmad(Founder/CMO)in Tammy Sun(Founder)inDavid Utley(Executive Officer, Director)

BoardSamir Kaul(Director)

Co-investorsAll Turtles Aurum Backstage Capital Core Venture Capital CRV (Charles River Ventures)Drive Capital +9 more

Cartesian Kineticscartesiankinetics.com in

Cartesian Kinetics develops "Physical AI" for fulfillment and warehouse operations, combining automation software and rack-native robotics that work within a facility's existing racks, systems and workflows rather than requiring a rebuild.

AI & Machine LearningHardwareLogistics & Supply ChainRoboticsSaaSSan Jose, US

Co-investorsCelesta Capital Celesta Capital Kae Capital

Casacasa.io in 𝕏

Casa provides self-custody solutions for bitcoin and stablecoins, offering multi-signature security infrastructure for both individual and institutional users.

Crypto & Web3Fintech

Nick Neuman(Founder & CEO)in

Co-investorsChampion Hill Ventures Fabric Ventures Fulgur Ventures STILLMARK Tioga Capital Partners Acrew Capital +4 more

Castlecastle.io in 𝕏

Castle builds trust infrastructure for the modern internet, helping organizations detect and prevent fraud and account takeover attacks.

CybersecurityDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Johan Brissmyr(Founder/CEO)in Sebastian Wallin(Founder/CTO)in

Board Shardul Shah in

Co-investorsIndex Ventures Y Combinator First Round Capital Walking Ventures Boost VC SparkLabs Global Ventures +1 more

Castlegetcastle.com inFeb 2019 · $9.2M

Castle builds payments infrastructure for homeowners, starting with a bill-pay app that helps them automate, consolidate, and reduce their household spending.

FintechPropTech

Co-investorsSuffolk Technologies Index Ventures Y Combinator

Castorcastoredc.com inSeries B · Jul 2021 · $45M

Castor provides a clinical trial data platform that combines electronic data capture, AI-assisted source data extraction with human review, and real-world evidence collection for medical device manufacturers, biopharma, diagnostics, and academic research teams.

AI & Machine LearningCloud ComputingData & InfrastructureDigital HealthHealthtechMedical DevicesSaaSAmsterdam, NL

Derk Arts(Founder)in

Co-investorsChartered Group Inkef Two Sigma Ventures

Chaos Labschaoslabs.xyz in 𝕏

Chaos Labs builds AI-driven intelligence and risk-management infrastructure that converts fragmented data into institutional-grade insights, offering risk simulations, parameter tuning, and oracle technology for crypto protocols and financial institutions.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Omer Goldberg(Founder & CEO)in

Co-investorsBalaji Srinivasan BlueYard Capital Coinbase Ventures Haun Ventures Lightspeed Venture Partners Samsung Next +9 more

Cipla Healthciplahealth.in in

Cipla Health is a consumer healthcare subsidiary that sells branded over-the-counter health products including throat lozenges, cough remedies, probiotics, oral care, and wellness supplements.

ConsumerHealthtechWellness & Fitness

Cloudantcloudant.com inAcquired

IBM Cloudant is a managed NoSQL database service based on Apache CouchDB, designed for building hyperscale, globally distributed applications with features including encryption, multi-region availability, full-text search, and geospatial indexing.

Cloud ComputingData & InfrastructureEnterprise SoftwareBoston, US

Michael Miller(Founder/Chief Scientist)inAlan Hoffman(Founder/Director of Product)inAdam Kocoloski(Founder/CTO)in

PartnerDavid Jegen· led

Co-investorsAvalon Ventures Management, Llc Carbide Ventures Toba Capital Y Combinator Masthead Venture Partners

Clstclst.com

CLST is a Zurich-based platform for institutional crypto and stablecoin lending with automated negotiation and risk assessment.

Michael Guzik(Founder)in

Co-investorsCoinbase Ventures Digital Currency Group SICTIC TX Ventures

Codeshipcodeship.com in 𝕏acquired by CloudBees

Cloud ComputingDeveloper ToolsEnterprise SoftwareSaaSBrookline Village, US

Moritz Plassnig(CEO)inSacha Labourey(Co-founder)François Déchery(Co-founder)Manuel Weiss(Executive Officer)inFlorian Motlik(Executive Officer)in

BoardJohn SImon(Director)

Co-investorsAscent Venture Partners Camber Partners Golub Growth Matrix NewView Capital Rembrandt Venture Partners +4 more

Coin Metricscoinmetrics.io in 𝕏

Coin Metrics provides market and on-chain data, reference rates, and indexes for crypto and digital assets, delivered to institutional investment teams via APIs.

Crypto & Web3Data & InfrastructureFintechBoston, US

Tim Rice(Founder)in

BoardMathew S. McDermott(Director)Sean Judge(Director)in Matt Scott Walsh(Director)in Nic Carter(Executive Officer, Director)inBob Davis(Director)in

Co-investorsAcrew Capital Coinbase Ventures Collab+Currency Communitas Capital Partners Digital Currency Group Dragonfly +3 more

Coincovercoincover.com in 𝕏

Coincover provides encryption-based protection and recovery for crypto private keys, sharding key material across independent parties so no single provider holds a complete key.

Crypto & Web3CybersecurityFintechCardiff, GB

David J.(Founder)inDavid Janczewski Adam Smith in

Co-investors13books Capital Insurtech Gateway Fund Element Ventures FinTech Collective Foundation Capital VOLT CAPITAL

ConnexPayconnexpay.com inOct 2022

ConnexPay provides a payment platform that lets businesses accept customer payments and fund immediate supplier payments via virtual cards from the same transaction, closing the cash flow gap.

FintechSaaSTravel & HospitalityBonita Springs, US

Robert Kaufman(Chief Executive Officer and member of the Board of Managers)in

Board Mark Buffington(Member of the Board of Managers)inJacob Eisen(Member of the Board of Managers)Pamela Joseph(Member of the Board of Managers)Barbara Polsky(Member of the Board of Managers)

Co-investorsBIP Ventures FTV Capital Tamiami Angel BIP Capital

Core Diagnosticscorediagnostics.in in 𝕏

Core Diagnostics offers diagnostic laboratory testing with sample collection services, including routine tests and diagnostic monitoring tests scheduled at defined intervals.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsArtiman Ventures Eight Roads Ventures

Countablecountable.com

Actionable is a self-service advocacy platform that lets organizations launch, manage, and measure campaigns such as petitions, pledges, lawmaker messages, and supporter mobilization without developers or consultants.

GovTechImpact & Social GoodSaaSOakland, US

Bart Myers(Executive Officer, Director)

Board Joydeep Bhattacharyya(Director)in

Co-investorsCanaan Partners Fernbrook Capital Management Silicon Valley

Countable Labscountablelabs.com in 𝕏Series A · May 2026 · $26M

Countable Labs (formerly Enumerix) develops Countable PCR, a DNA quantification technology that provides absolute target counts at single-molecule resolution as an alternative to qPCR, digital PCR, and NGS.

BiotechDeep TechHealthtechMedical DevicesPalo Alto, US

Stephen Fodor(Co-Founder & Board Director)Ari Chaney(Co-Founder & Board Director)in Christina Fan(Co-founder + CTO)inGiovanna Prout(Chief Executive Officer)in

Co-investorsARCH Venture Partners Primer Ventures

Curegenix Corporationcuregenix.com

Curegenix is a clinical-stage biopharmaceutical company founded in 2009 that develops small-molecule drugs targeting the WNT signaling pathway, including lead candidate CGX1321, for cancer and tissue repair, with operations in California and Guangzhou, China.

Curie Biocurie.bio in

Curie.Bio is a biotech venture firm pairing seed capital with in-house drug discovery support for therapeutics founders.

Zach Weinberg(Founder)in

Co-investorsAlleyCorp ARCH Venture Partners DNA Capital GV (Google Ventures)Shine Capital Alley Robotics Ventures +1 more

Curvancecurvance.com 𝕏

Curvance is a decentralized finance protocol that combines depositing, borrowing, leveraging, swapping, and yield earning into a single dashboard.

Crypto & Web3Fintech

Co-investorsV3V Ventures Yunt Capital Curve Flowdesk FRAX Finance GSR +2 more

Cyclopscyclops.io in 𝕏

Cyclops is a unified crypto and stablecoin platform built specifically for payments companies, combining licensing, custody, compliance, and 24/7 settlement into a single integration.

Crypto & Web3FintechSaaS

Alex Wilson(Founder)in

Co-investorsNava Ventures Castle Island Ventures Circle & Co.Coinbase Ventures

Dataplordataplor.com in 𝕏Series B · Jun 2025 · $21M

Dataplor provides global point-of-interest, mobility, and brand location data with AI-powered analytics for investors to assess market share, growth trends, and foot traffic.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechRetail TechSaaS

Co-investorsAPA Venture Partners Blue Ivy Ventures Circadian Ventures Ff Venture Capital Magma Partners Navigate Ventures +4 more

Deal Enginedealengine.tech inNov 2022 · $5.3M

Deal Engine provides a white-labeled, AI-powered data platform that helps private equity firms and investment banks identify and progress deals in real-time by codifying coverage strategies and delivering actionable market intelligence across integrated systems.

AI & Machine LearningEnterprise SoftwareFintechSaaSLondon, GB

Phil Westcott(CEO)in

Co-investorsFINTOP Capital

Deal Enginedeal-engine.comNov 2022 · $5.3M

Deal Engine provides automated refund and change management solutions for the travel industry.

AI & Machine LearningSaaSTravel & HospitalityMiami, US

Co-investorsDorm Room Thayer Ventures

Devoted Healthdevoted.comSeries A · Oct 2017 · $62M

Devoted Health offers Medicare Advantage plans and integrated healthcare services for older Americans, including virtual and in-home care, member support guides, and coordination with local providers across 29 states.

HealthtechInsurTechUnited States, US

Todd Park(Co-founder)inEd Park(Co-founder)in

Board Bryan Roberts(Director)in Robert Kocher(Director)in William Frist(Director)inKathleen Sebelius(Director)

Co-investorsAndreessen Horowitz Bronze Investments Capital Factory Dns Capital Dreamers VC FPV +18 more

Dimension Therapeutics inApr 2015acquired by Ultragenyx Pharmaceutical · Oct 2017 · $152.3M

Dimension Therapeutics was a Cambridge, Massachusetts biopharmaceutical company developing AAV-based gene therapies for rare liver-associated metabolic diseases like hemophilia, OTC deficiency, and glycogen storage disease.

Cambridge, US

Annalisa Jenkins(Executive Officer, Director)

BoardBenjamin Auspitz(Director)Donald J. Hayden(Director)Allan Fox(Director)

Co-investorsNew Leaf Venture Partners OrbiMed

Dinaridinari.com in 𝕏

Dinari provides tokenized stocks and ETFs (dShares) that combine traditional equity securities with blockchain-based digital assets, serving financial institutions like neobanks, fintechs, brokerages, and institutional traders across 85+ jurisdictions.

Crypto & Web3FintechPalo Alto, US

Gabriel Otte(Executive Officer, Director)in Altay Malazgirt inJake Timothyin

Co-investors500 Global Alliance DAO (ex DeFi Alliance)Hack VC Sancus Ventures Silvermine Capital Blockchange Ventures +1 more

Dispatch iodispatch.io in

Dispatch is a data orchestration platform that connects wealth technology software by automating client data collection and synchronization across advisory firm tech stacks.

Data & InfrastructureEnterprise SoftwareFintechSaaS

Rob Nance(Co-founder, CEO)in Madalyn Armijo(Co-founder, COO)in Rafi Lurie(Co-founder, CPO)in

Co-investorsBrewer Lane Ventures Fika Flyover Capital MassMutual Ventures New York Life Ventures Perceptive Ventures Management Company, Llc +3 more

Docereedoceree.com in 𝕏Series A · Sep 2023 · $35M

Doceree offers a software platform for pharmaceutical brand teams, positioned as a single "system of work" that unifies market research, HCP targeting, media planning, measurement, CRM, and MLR workflows in place of fragmented tools.

AdTechDigital HealthMarketing TechSaaSShort Hills, US

Harshit Jain(Founder & Global CEO)in Kamya Elawadhi(Co-Founder & President)inPulkit Jain(VP - Finance & Investments)in Vijay Adapala(Chief Business Development Officer)inThomas Shea(Chief Revenue Officer, AI and Patient Affordability Solutions)inYesh Srinivasan(Chief AI Officer)

Co-investorsAlkemi Growth Capital Eight Roads Ventures

Dust Identitydustidentity.com inJul 2019

Dust Identity develops physical identity solutions using diamond-based technology to authenticate and trace high-value products and components across supply chains.

Circular EconomyDeep TechDefense TechEnterprise SoftwareHardwareIoTNew MaterialsRetail TechNeedham, US

Ophir Gaathon(Executive Officer, Director)inDirk Englund(Executive Officer, Director)

Board Ilya Fushman(Director)in

Co-investorsAngular Ventures Grit Ventures New Science Ventures American Express Ventures (Amex)Kleiner Perkins Lockheed Martin Ventures

Eaglebrook Advisorseaglebrook.com in

Eaglebrook is a crypto investment platform for wealth managers, offering tax-optimized Bitcoin, Ethereum, and multi-asset separately managed accounts (SMAs) held in segregated accounts at qualified custodians.

Crypto & Web3FintechSaaS

Christopher King(Founder)in

Co-investorsBrewer Lane Ventures Avon Ventures Castle Island Ventures Flyover Capital Franklin Templeton Gemini Frontier Fund +2 more

Eigeneigen.io inAug 2026 · $20M

Eigen Innovations develops AI vision software and solutions for manufacturing enterprises to enable digital transformation and improve operational efficiency.

Advanced ManufacturingAI & Machine LearningEnterprise SoftwareHardware

Paul Scherer(Founder)in Erin Barrett(Chief Executive Officer)in

Co-investorsCeltic House Asia Partners East Valley Ventures Momenta Ventures AGI HOUSE VENTURES Aramco Ventures Benchmark +7 more

Elementuselementus.io in

New York, US

Max Galka(Executive Officer, Director)inNuria Gutiérrez Prunera(Founder)Chris Lipowicz inVladimir Jelisavcic(Director)

Board Anthony Pompliano(Director)in

Co-investorsMoonshots Capital ParaFi Capital Velvet Sea Ventures Avon Ventures Gemini Frontier Fund Lightspeed Venture Partners +2 more

Eleoseleos.co.uk in 𝕏Nov 2023 · $40M

Eleos offers life insurance and income protection to consumers in the UK, with an app-based process that explains cover in plain English, provides instant answers, and connects users to licensed experts by WhatsApp, email, or phone.

FintechInsurTech

Co-investorsFuel Ventures Heartfelt Capital Eight Roads Ventures Greenfield Partners Lool Ventures Menlo Ventures +1 more

Eleos Healtheleos.health inSeries A · Nov 2023 · $40M

Eleos develops AI-powered software that helps behavioral health clinicians deliver more effective care through data measurement and personalization.

AI & Machine LearningDigital HealthHealthtechMental HealthCambridge, US

Alon Joffe(Chief Executive Officer)inDror Zaide(Chief Revenue Officer)inAlon Rabinovich(Chief Technology Officer)in Denny Morrison(Chief Clinical Officer)in Raz Karmi(Chief Information Security Officer)in Noam Cohen(VP of R&D)in

Co-investorsaMoon Arkin Capital Greenfield Partners Lool Ventures Maccabee Ventures Menlo Ventures +2 more

Elucidataelucidata.io in 𝕏Series A · Sep 2022 · $16M

Elucidata is a company oriented around supporting scientific research, emphasizing making users' research more efficient and respecting the scientific method.

AI & Machine LearningBiotechData & InfrastructureCambridge, US

Abhishek Jha(Co-founder & CEO)Swetabh Pathak(Director)in

Co-investorsHyperplane Venture Capital Eight Roads Ventures IvyCap Ventures

Embarkembarkvet.com in 𝕏

Embark Veterinary develops dog DNA tests and science-backed supplements for dog health and genetics.

BiotechConsumerHealthtech

Amish Desai(Chief Executive Officer)in Tali Ronen(SVP, People)inGrace Carter(VP, Finance)in

Co-investorsDCVC (Data Collective)FundersClub Peak Partners Slow Ventures SoftBank Vision Fund Sequoia Capital

Engrail Therapeuticsengrail.com inSeries B · Mar 2024 · $170M

Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.

BiotechDigital HealthMedical DevicesSan Diego, US

Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)inVikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)

Co-investorsForesite Capital Longwood Fund Norwest Venture Partners RiverVest Venture Partners Ysios Capital abrdn plc +4 more

Enzene Biosciences Ltdenzene.com in 𝕏Jan 2023 · $50M

Enzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals.

Advanced ManufacturingBiotechHealthtechMedical Devices

Co-investorsEight Roads Ventures

Equipequip.health in 𝕏

Equip provides virtual care and treatment services for eating disorders through a digital platform.

Digital HealthHealthtechMental Health

Kristina Saffran(Co-founder)in Erin Parks(Co-founder, clinical psychologist)in

Co-investors.406 Ventures Coalition Operators Optum Ventures PLUS Capital The Chernin Group (TCG Crypto)

Eris Innovationserisfutures.com in

Eris Innovations is an intellectual property licensing company that developed and patented the Eris Methodology, a way to list exchange-traded futures replicating interest rate swaps, which it licensed to CME Group for Eris SOFR Swap futures and Eris Options.

Fintech

Michael Riddle(Chief Executive Officer)in

Co-investorsChicago Trading Company Virtu Financial

Ethena Labsethena.fi 𝕏

Ethena operates a crypto protocol offering USDe, a digital dollar, and sUSDe, a reward-accruing asset backed by collateralized assets with third-party attestations.

Crypto & Web3Fintech

Guy Young(Founder & CEO)in

Co-investorsAlphaLab Capital BitDAO Breed Caladan CVP NoLimit Faction +17 more

EurekaBioeurekabio.com in

EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions.

BiotechDeep TechHardwareHealthtechMedical DevicesShenzhen, CN

Co-investorsMing capital

Even Financialevenfinancial.com inSep 2019Acquired

Even Financial, operating as Engine, runs a financial services marketplace and matching network that connects consumers with financial products through APIs and white-labeled experiences.

AI & Machine LearningFintechMarketplacesBrooklyn, US

Phill Rosen(Founder & CEO)Ian Rosen(Executive Officer, Director)Jarid Maged(Executive Officer, Director)

Board Brendan Dickinson(Director)in

PartnerDavid Jegen· led

Co-investorsAAF Management Ltd.Conversion Capital GreatPoint Ventures MassMutual Ventures Valuestream Ventures Canaan Partners +5 more

Expressableexpressable.ioFeb 2022 · $15M

Austin, US

Nicholas Barbara(Executive Officer, Director)inLeanne Sherred(Executive Officer, Director)inBenjamin Pincus(Executive Officer)Spencer Magloff(Executive Officer)Ryan Hinojosa(Executive Officer)

Co-investorsNextView Ventures HarbourVest Partners (Canada)Lerer Hippeau

Expressableexpressable.com inMay 2024 · $26M

Expressable provides speech therapy services using research-based techniques with a focus on family engagement and accessibility.

Digital HealthHealthtechSaaS

Leanne Sherred(President and Chief Clinical Officer)in

Co-investorsDigitalis Ventures HarbourVest Partners (Canada)Lerer Hippeau

Eyebright Medicalebmedical.com

Eaglet Eye Medical (Aibo Medical) is a China-based manufacturer of ophthalmic medical devices covering eye surgery treatment, myopia control, and vision care.

Advanced ManufacturingHealthtechMedical DevicesBeijing, CN

Eywaeywa.bio in

Eywa is a team of scientists and innovators focused on advancing mental health through research and partnerships.

BiotechDeep TechDigital HealthHealthtechMental Health

Co-investorsDraper Associates Ganesha Lab GRIDX ah! Ventures

FalconXfalconx.io in 𝕏

FalconX is a digital assets prime brokerage providing institutional clients with 24/7 access to liquidity and capital solutions through proprietary technology designed for risk management in volatile markets.

Crypto & Web3FintechSan Mateo, US

Raghu Yarlagadda(Founder)in Austin Reid in Suzy Walther in Brian Crist in Vanessa Zhang in

Board Shekhar Kirani(Executive Officer, Director)in

Co-investorsAccel Accomplice B Capital Group B4 Capital Cleo Capital Coinbase Ventures +13 more

Figmentfigment.io in 𝕏

Figment is an independent provider of staking infrastructure, offering non-custodial staking, reward tracking, API integrations, and slashing protection to institutional clients such as asset managers, exchanges, wallets, foundations, and custodians.

Crypto & Web3Data & InfrastructureEnterprise SoftwareFintech

Lorien Gabel(Founder & CEO)in

Co-investors10SQ Capital (TenSquared)3cubed Ventures AppWorks Ventures Archetype B Capital Group B4 Capital +12 more

Firefly Healthfirefly.health inSep 2019 · $10.2M

Firefly Health operates an advanced virtual care platform designed to deliver primary care services with a focus on equity, affordability, and personalized patient outcomes.

Digital HealthHealthtechInsurTech

Andy Ellner(Chief Clinical Advisor)in Jeff Greenberg(Founder)inFay Rotenbergin

Co-investorsAndreessen Horowitz MaC Venture Capital Oak HC/FT Premji Invest Jam Fund

Firefly Healthfireflyhealth.com inSep 2019 · $10.2M

Firefly Health provides virtual primary care through dedicated care teams that include primary care physicians, nurse practitioners, health guides, nurses, and behavioral health specialists.

Digital HealthHealthtechInsurTechMental Health

Jeff Greenberg(Founder)inFay Rotenbergin

Co-investorsEast 11 Ventures Floating Point Andreessen Horowitz Oak HC/FT

Flipside Cryptoflipsidecrypto.com

Edisyl builds a semantic layer that encodes organizational understanding of data meaning, metrics definitions, and institutional knowledge to enable enterprise AI tools to answer questions aligned with business logic.

AI & Machine LearningData & InfrastructureEnterprise Software

Jim Myers(Founder)in

Co-investorsBoston Seed Capital Coinbase Ventures Converge The Chernin Group (TCG Crypto)Avon Ventures Blockchain Coinvestors +13 more

Flourish Healthflourish.healthSeries A · Jul 2026 · $26M

Flourish Health provides in-home mental health care for young people with serious psychiatric needs, combining clinical expertise with technology to deliver evidence-based treatment through multidisciplinary care teams.

Digital HealthHealthtechMental HealthNorth Carolina, US

Natalia Birgisson(CEO and Co-Founder)John Haskell(Co-Founder and President)Josh Gachnang(Co-Founder and Chief Technology Officer)

Co-investors25Madison Acumen America AV8 Ventures B Capital Group City Light Gratitude Railroad+5 more

Funnelfunnel.io in 𝕏

Funnel is an AI-native marketing data platform that aggregates, models, and governs marketing data from 600+ sources into a single layer, then adds measurement and reporting on top.

AI & Machine LearningData & InfrastructureMarketing TechSaaSStockholm, SE

Co-investorsBalderton Capital Industrifonden NavisionGroup Oxx RET Ventures Trinity Ventures +2 more

FutureAdvisorfutureadvisor.comacquired by BlackRock

FutureAdvisor provides digital wealth management services to middle- and upper-middle-income households, offering automated portfolio management and financial advice at lower costs than traditional advisory firms.

FintechSan Francisco, US

Bo Lu(Founder/CEO)in

PartnerDavid Jegen· led

Co-investorsCanvas Ventures Kapor Capital Y Combinator Sequoia Capital

Galatea Biogalatea.bioAug 2024 · $8M

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

HealthtechMiami Lakes, US

Carlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)

Board Wale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)

Co-investorsCEI Ventures Citta Capital Founder Collective Function Ventures Helios Digital Ventures LifeX Ventures +2 more

Geneceptionskytx.com in

Skyline Therapeutics develops gene therapy vector technology and supports clinical development for therapeutic applications using genetic science approaches.

BiotechDeep TechHealthtech

Co-investorsLAV Lilly Asia Ventures

Genoa Pharmaceuticalsgenoa-pharmaceuticals.appspot.com

Avalyn Pharma (formerly Genoa Pharmaceuticals) is a biopharma company developing inhaled therapies for idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.

BiotechHealthtechSan Diego, US

Mark W. Surber, Ph.D.(Executive Officer, Director)Richard G. Vincent(Executive Officer)

BoardMichael J. Kamdar(Director)Daniel D. Burgess(Director)

Co-investorsNorwest Venture Partners RiverVest Venture Partners Sofinnova Ventures

Genomicsgenomics.cnSeries B · Dec 2018 · $9M

BGI (Huada) is a genomics research and services organization offering clinical genetic testing, scientific research services, forensic/judicial testing, and sequencing instruments.

BiotechDeep TechDigital Health

Wang Jian(Founder)

Co-investorsForesite Capital Green Pine Capital Partners

Genomics Plcgenomics.com in 𝕏

Genomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers.

AI & Machine LearningBiotechDigital HealthHealthtechOxford, GB

Peter Donnellyin

Co-investorsForesite Capital

Grovegrove.city

Grove, originally founded as Pocket Network Inc., built decentralized infrastructure including the Pocket Network protocol and the Grove Portal gateway serving blockchain data access.

Creator EconomyCrypto & Web3Data & Infrastructure

Michael O'RourkePabel Nunezin Luis de Leon in

Co-investorsBorderless Venture Outliers VC

Gst Clinicsgstzy.cn

Gushengtang operates a chain of traditional Chinese medicine (TCM) clinics, running 101 offline TCM facilities across 21 Chinese cities and Singapore with an online-plus-offline (OMO) service model supported by internet and AI technology.

AI & Machine LearningDigital HealthHealthtechWellness & FitnessGuangzhou, CN

Co-investorsNew Enterprise Associates (NEA)AGP

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Amphora Medical Checkmate Pharmaceuticals Embark Veterinary, Inc.Parrot Technologies Inc / DE4118Abelian TherapeuticsAccuri CytometersAerium TherapeuticsAirespaceAkriveia TherapeuticsAlphagen TherapeuticsAlphaGen TxARTBIOB One OrthoBang Er MedicalBetter Life MedicalBikam PharmaceuticalsBioconnect SystemsBiopaletteBTP AutomationCanoeCardioklineCentivoCitrine MedicineDigital Assets DataEquip HealthFarapulseFazeshiftFcb HealthFoldrxFoldRx PharmaceuticalsGeotel

Browse all 445 investments with full details →

▶245 more tracked companies

GurosGyennoHealth TechnologyHealthcare North America Growth StageHealthcare North America Growth StageHealthtech + ServicesHercle HilabsHile BiopharmaHone Hone Group HosekiHq Medical TechnologyHua Medicine Hurdle iCertis, Inc.IgluIkano TherapeuticsImmuneel ImmutrinIndalo TherapeuticsInnoventInnovent BiologicsInsilico Medicine Intuition Invetx Iora Health Iriva Medical Ironwood Pharmaceuticals Ivenix Judi Jump K36 TherapeuticsK36 TxKanastra KenshoKilnKintsuKnowyourselfKyruus LakeShore Biopharma Latchel Laurus Bio Laurus LabsLeadiqLemonLenomedLiazonLighthouseLigocyteLimitless ExchangeLogixboard LunaPBC Madaket Marit Health MarketMuseMddfMediTrust HealthMedwellMeldMersana Metcela MetseraMindshiftMineralTreeModis TherapeuticsMoEngage Monark Markets MozperMyolabMythical Games Nanos MedicalNapsterNava Therapeutics nChroma Bio Nebula Genomics Neo4j NeuroSmart Inc.Nextwavepharma nocd Nocion Therapeutics Nodthera NotableNovamed PharmaceuticalsNuance CommunicationsNvelop TherapeuticsNYDIGOakley NetworksOdaseva OncoveryCare Oncusp TherapeuticsOnCusp TxOpennode Optimus Ride Orchard TherapeuticsOrient Speech Therapy OstOrigynmed Oviva PRIVATE DEBTOwncloud IncOxioOziva Papaya Paradigm HealthParrotPathPatientPingPediatrixPediatrix TherapeuticsPeptonePercyPharmEasyPiePing Identity Plasmagen Biosciences Plume NetworkPortfolio Category AiPortfolio Category CryptoPortfolio Category EnterprisePortfolio Category FintechPortfolio Category FrontierPortfolio Category MedtechPortfolio Category TherapeuticsPortfolio Region AsiaPortfolio Region EuropePortfolio Region NaPortfolio Region South AmericaPortfolio Status AcquiredPortfolio Status PrivatePortfolio Status PublicProcured HealthPromentis Pharmaceuticals Prosper ProtenusProteostasis TherapeuticsProximie Puffer Finance Pulmocide Quantum Circuits Quarry Thera Quartet Health QuovoR1 TherapeuticsRareStone GroupRareStone Group (Previously Citrine Medicine)ReadmeReceipts Depositary CorporationRecurly Redpine Regenx BiosciencesRemunixRespivertRhyGaze AG Rialtic RightHand Rigimmune RIPPL Care RisklensRiskreconRoarkRugen TherapeuticsSana Biotechnology Securonix Semma TherapeuticsSemma TxSeyond Shift Bioscience Shinobi Therapeutics Inc.Shinobi TxSilexonSilicon DataSilqSimonSingular GenomicsSingular Genomics Systems SironaxSkyline TxSnapsheet Solidus LabsSolv ProtocolSonderMind Space and Time Spectrumai Spinwheel Spry Stride HealthStructure TherapeuticsSTS DigitalSurface OncologySymbiomixSymbiomix Therapeutics T Therapeutics TandemaiTct Medical IncTeam Sector CryptoTeam Sector Life SciencesTeam Sector TechnologyTeleoTenpoint Therapeutics Tenvie Tetraphase Pharmaceuticals The Giving BlockTokensoftToku TokuTokuToku TokuTopaz PharmaceuticalsTraceLinkTradeblockTransaveTreeent Trivitron HealthcareTruth SystemsTurnstone BiologicsTwin1 AiU S HealthVest Ultragenyx Unbox RoboticsUnbxdUnlocking mRNA deliveryUnlocking private, uncensored AIValor HealthValrVendrVeridVerve Therapeutics VestwellVicept TherapeuticsVitalwareVyne Therapeutics Wanhu Healthcare Warmly,Welbe Health well beam Wellframe WhatfixWintermuteWww Akrevia ComXaira TherapeuticsXoomYishengbioZeen Health ジェイファーマ株式会社思派健康 (0314.HK)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 76

25 IPOs · 51 acquisitions · showing 36

Caribou BiosciencesNASDAQ: CRBUNeumora TherapeuticsNASDAQ: NMRApeerTransferNASDAQ: FLYWShouTi Inc.NASDAQ: GPCRXilio TherapeuticsNASDAQ: XLOAclaris TherapeuticsNASDAQ: ACRSAdageneNASDAQ: ADAGAdaptimmuneOTC: ADAPYAvalyn Pharma IncNASDAQ: AVLNBeam TherapeuticsNASDAQ: BEAMBicara TherapeuticsNASDAQ: BCAXCoherus BiosciencesNASDAQ: CHRSCoinbaseNasdaq: COINCompass TherapeuticsNASDAQ: CMPXCytek BiosciencesNASDAQ: CTKBDenali TherapeuticsNASDAQ: DNLIFLYWIRENASDAQ: FLYWInsmedNASDAQ: INSMPrecision BioSciencesNASDAQ: DTILPrime MedicineNASDAQ: PRMERallybio, LLCNASDAQ: RLYBToastNYSE: TOSTUnum TherapeuticsNASDAQ: COGT小马智行 (NASDAQ: PONY)NASDAQ: PONYAmphora Medicalacq. by HologicCheckmate Pharmaceuticalsacq. by Regeneron PharmaceuticalsAbelian Therapeuticsacq. by Neumora TherapeuticsAirespaceacq. by Cisco SystemsBikam Pharmaceuticalsacq. by ShireBison Trailsacq. by CoinbaseCodeshipacq. by CloudBeesDimension Therapeuticsacq. by Ultragenyx PharmaceuticalFarapulseacq. by Boston ScientificFoldrxacq. by PfizerFutureAdvisoracq. by BlackRockGeotelacq. by Cisco Systems

Portfolio news

latest coverage across their companies

F-Prime Capital to give insights on the state of robotics investments at RoboBusiness - The Robot Report

F-Prime Capital · therobotreport.com · Sep 18, 2026

STS Digital launches institutional investment strategies

STS Digital · royalgazette.com · Sep 17, 2026

Preferred Return vs Hurdle Rate: Why Sponsors Confuse the Two and Investors Don't - Park Magazine NY

Hurdle · parkmagazineny.com · Sep 11, 2026

Judi Health adds Color Health, WellTheory, Cylinder to benefits platform | MobiHealthNews

Judi · mobihealthnews.com · Sep 10, 2026

How Equity Raise Concerns Will Impact Alibaba Stock Investors - Simply Wall St News

Alibaba · simplywall.st · Sep 9, 2026

Prime Medicine to Participate in Upcoming September 2026 Investor Conferences - BioSpace

Prime Medicine · biospace.com · Sep 3, 2026

Cantor Fitzgerald raises Coinbase stock price target on crypto momentum By Investing.com

Coinbase · investing.com · Aug 31, 2026

Tenpoint Therapeutics launches with $70 million in funding for cell therapy platform | Eye Care Network - Ophthalmology Times Europe

Tenpoint Therapeutics · ophthalmologytimes.com · Aug 30, 2026

IPO stake values · per SEC filings · 2

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

Company	Owned	IPO price	At IPO	Stake value
peerTransfer	7.3%	$24.00	May 2021	$179M
FLYWIRE	7.3%	$24.00	May 2021	$179M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has F-Prime Capital made?: F-Prime Capital has 445 tracked investments, 76 of which have exited, including 23 dated in the last 24 months.
What stage does F-Prime Capital invest at?: F-Prime Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is F-Prime Capital's typical check size?: F-Prime Capital typically writes checks of $3M – $10M.
What sectors does F-Prime Capital focus on?: F-Prime Capital focuses on Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, SaaS, Sector Agnostic.
Where is F-Prime Capital located?: F-Prime Capital is headquartered in Cambridge, US.
Does F-Prime Capital lead rounds?: Yes, F-Prime Capital leads investment rounds.
Who does F-Prime Capital co-invest with?: F-Prime Capital most often shares deals with ARCH Venture Partners, GV (Google Ventures), Eight Roads Ventures, among 677 tracked co-investors.

Images

Co-investors · 166

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

Both backed · 44

Adagene Adaptimmune Beam Therapeutics Bicara Therapeutics Abk Biomedical Inc Adcentrx Therapeutics Affinia Therapeutics Alibaba AppsFlyer Arnatar Therapeutics AvenCell Beads Bioregen Carestack Core Diagnostics Doceree Eleos Eleos Health Elucidata Engrail Therapeutics Enzene Biosciences Ltd Hua Medicine Insilico Medicine Invetx K36 Therapeutics Laurus Bio Laurus Labs Lighthouse MineralTree Odaseva Oziva Proximie Securonix Semma Therapeutics Seyond Sironax Spry Threat Stack WhatfixAlphagen TherapeuticsB One OrthoBetter Life MedicalBiopaletteBTP Automation

$5M – $30M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M

ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.

$50K – $250M

Foresite Capital

Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.

Both backed · 16

Aclaris Therapeutics Adaptimmune Beam Therapeutics Bicara Therapeutics Compass Therapeutics Denali Therapeutics Insmed Blueprint Medicines Engrail Therapeutics Generation Bio Genomics Plc Orchard Therapeutics Verve Therapeutics Xaira TherapeuticsGenomicsStructure Therapeutics

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

Both backed · 14

Adaptimmune Affinia Therapeutics Amber Therapeutics AviadoBio Website Black Duck CHARM Therapeutics Comanche Biopharma Gst Clinics Mersana Stride Health Tempest Therapeutics Xaira TherapeuticsProteostasis TherapeuticsSurface Oncology

$200K – $40M

OrbiMed

OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

Both backed · 13

Compass Therapeutics Insmed Adela Carrot Fertility CHARM Therapeutics Dimension Therapeutics Insilico Medicine Oncusp Therapeutics Promentis Pharmaceuticals Symbiomix Therapeutics Tandemai Turnstone Biologics Viewray

$1M – $75M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

Both backed · 12

Avalyn Pharma Inc FalconX Figment iCertis, Inc.Insilico Medicine Judi MoEngageARTBIOCentivoFlourish HealthHealthcare North America Growth StageMediTrust Health

$10M – $50M

Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.

Both backed · 11

Coinbase Benchling Devoted Health Dispatch io Firefly Health Intuition Mythical Games Nava Therapeutics PatientPing Prosper Zus Health

$500K – $50M

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

Both backed · 11

Insmed Toast Artemis Health CandidPro Eigen NYDIG Papaya Peptone PharmEasyLiazonTwin1 Ai

$5M – $100M

Sofinnova Ventures

Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.

Both backed · 11

Aclaris Therapeutics Coherus Biosciences Checkmate Pharmaceuticals Genoa Pharmaceuticals Nextwavepharma Oncusp Therapeutics RarecyteApellisARTBIOHealthcare North America Growth StageProteostasis Therapeutics

$100K – $15M

.406 Ventures

.406 Ventures is an early-stage venture capital firm that partners with founders building companies in healthcare, data and AI, and cybersecurity.

Both backed · 10

Better Life Partners Bluebird Kids Health Equip Equip Health Hurdle Iora Health MineralTree OncoveryCare Threat Stack Welbe Health

$1M – $4M

General Catalyst

General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.

Both backed · 9

Almanac Health Black Duck Devoted Health Equip Health Intuition Judi Paradigm Health RIPPL Care SonderMind

$30M

▶154 more co-investors

SoftBank Vision Fund Atlas Venture RA Capital Venrock Alumni Ventures Menlo Ventures Spark Capital Canaan Partners Oak HC/FT Digital Currency Group Tiger Global Management Lux Capital Polaris Partners 5AM Ventures Vivo Capital RiverVest Venture Partners Volition Capital Sequoia Capital Accel Khosla Ventures Insight Partners Bain Capital Ventures QED Investors Sanofi Ventures Digitalis Ventures Optum Ventures Lightstone Ventures Greylock Partners Foundation Capital Gradient Ventures NextView Ventures Lerer Hippeau Social Leverage Fika 9Yards Capital MassMutual Ventures JAZZ Venture Partners Sofinnova Partners Cambridge Innovation Capital Pivotal Life Sciences Brewer Lane Ventures Nextech Invest Advent Life Sciences Omega Funds Casdin Capital Index Ventures Founder Collective Benchmark Kleiner Perkins Plug and Play Ventures Forerunner Ventures Inovia Capital Winklevoss Capital Citi Ventures Ff Venture Capital Dawn Capital Xfund EQT Life Sciences Jump Capital Versant Ventures Maven Ventures Third Rock Ventures Abingworth Flagship Pioneering Arboretum Ventures Arthur Ventures Baird Capital aMoon Flyover Capital Anterra Capital AIF Red Tree Venture Founders Fund Craft Ventures Redpoint Ventures First Round Capital CRV (Charles River Ventures)Eniac Ventures FundersClub Freestyle Capital SignalFire Scale Venture Partners Canvas Ventures Maveron Pear VC US Venture Partners Creandum Two Sigma Ventures Threshold Ventures TCV Flourish Ventures American Express Ventures (Amex)Founders' Co-op Accelerator Ventures Jackson Square Ventures Golden Ventures BDC Venture Capital Kickstart Pitango Forum Ventures Arrive Forbion SparkLabs Global Ventures 7wire Ventures Zelkova Ventures GPO Fund Inkef Town Hall Ventures Illuminate Financial Questa Capital Brighton Park Capital CVS Health Ventures DFJ Bluebird Ventures De Novo Ventures Helios Digital Ventures Alkemi Growth Capital Great Oaks Venture Capital Streamlined Ventures RRE Ventures UpHonest Capital Headline IA Ventures Upfront Ventures Wing General Partnership Dell Technologies Capital Better Tomorrow Ventures Saga Ventures Brainchild Holdings Company Capital Heartcore Capital Work-Bench Mucker Capital Nyca Partners Highbury Holdings Rubicon Venture Capital IrishAngels Stripe Bread And Butter Ventures, Llc Page One Ventures Venture Guides Management, L.P.Picture Capital In-Q-Tel Surface Ventures HealthQuest Capital Fireblocks 4BIO Capital Vendep Capital JMI Equity Neon Adventures Nina Capital International Finance Corporation WillowWorks

Firms observed investing alongside F-Prime Capital, from public investor directories. Shared companies are the overlap with F-Prime Capital's recorded portfolio.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Khosla Ventures

Khosla Ventures is a venture capital firm founded by Vinod Khosla.

$5K – $50M

Olive Tree Capital

Olive Tree Capital is a venture capital firm that invests in founders building at the technological frontier.

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M

Featured in lists

Investors & VC Firms in North America Investors & VC Firms in United States Seed Investors & VC Firms Series A Investors & VC Firms Pre-Seed Investors & VC Firms Seed Investors & VC Firms in North America Investors & VC Firms in Europe Seed Investors & VC Firms in United States Growth Investors & VC Firms Crypto & Web3 Investors & VC Firms Series A Investors & VC Firms in North America Series B Investors & VC Firms

Website & socialfprimecapital.com

/f-prime-capital-partners @fprimecapital watch video

signal ↗crunchbase ↗Blog ↗

As published on the firm's website.

Contact

Cambridge1 Main St.
13th Floor
Cambridge, MA 02142
United States

London33 Foley Street
London W1W 7TL
United Kingdom

San Francisco140 New Montgomery Street
2nd Floor, Suite A
San Francisco, CA 94105
United States

Emailinfo@fprimecapital.com

Phone617-231-2400

Fax617-231-2425

FoxScore

Combines investment activity, responsiveness, founder feedback, closing rate and follow-through reported by founders on Fox. Sign up to see it.

Your history

F-Prime Capital isn't in your CRM yet.

+ Add to CRM

Track outreach, deck opens, and next steps across your whole raise.

✨ Smart outreach

✨ Best warm path

Funds

IMPRESA FUND IV LLCJun 2026 · 301 LPs$3.5BAUM

FMR CAPITAL HOLDINGS LLCJun 2026 · 298 LPs$3.1BAUM

IMPRESA FUND III LPJun 2026 · 138 LPs$2.7BAUM

42 NORTH RESOURCE PARTNERS II LPJun 2026 · 2 LPs$609.3MAUM

F-PRIME CAPITAL PARTNERS HEALTHCARE FUND V LPJun 2026 · 9 LPs$608.9MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VII LPJun 2026 · 9 LPs$606.3MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND IX LPJun 2026 · 2 LPs$498.5MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VIII LPJun 2026 · 9 LPs$463.4MAUM

IMPRESA FUND VJun 2026 · 200 LPs$404.6MAUM

F-PRIME CAPITAL PARTNERS TECH FUND II LPJun 2026 · 9 LPs$358.2MAUM

DI CONSUMER FUND I LPJun 2026 · 2 LPs$352.8MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VI LPJun 2026 · 9 LPs$294.3MAUM

Source: SEC Form ADV Schedule D and EDGAR Form D filings. AUM is gross asset value as reported by the adviser.

Latest on 𝕏

F-Prime @fprimecapital

Nava Therapeutics is building next-gen lipid nanoparticles to do exactly that — targeting T cells, the kidney, and beyond. Proud to back the team as they emerge with $89M and head toward the clinic. 🧬 https://t.co/IVtAWuXrKC

Jul 15, 2026 · ♥ 3 · ⇄ 2

F-Prime @fprimecapital

AJ Loiacono spent years auditing PBM contracts and found a system obscuring costs rather than lowering them. His conclusion: real change would require rebuilding from within. In 2017, he did exactly that. Now @judihealth covers 58M+ lives. Full Q&A👉https://t.co/VyLpJohFgn

Jun 25, 2026 · ♥ 3

F-Prime @fprimecapital

F-Prime is honored to be named as a top investor for #GenAI & #mentalhealth in Galen Growth's 2024 report of the Health Tech 50 Core Investors. #HealthTech 50 report provides a deep dive into the top investors revolutionizing the digital health landscape: https://t.co/z2eNHLwEPf https://t.co/ObB1DmQaYp

Feb 6, 2025 · ♥ 9